https://curecurrent.com/trials/paclitaxel-carboplatin-and-radiation-therapy-in-treating-patients-who-are-undergoing-surgery-for-stage-iii-non-small-cel-50472 https://curecurrent.com/trials/a-study-of-emibetuzumab-in-non-small-cell-lung-cancer-nsclc-participants-50473 https://curecurrent.com/trials/a-study-of-advanced-or-metastatic-non-small-cell-lung-cancer-50474 https://curecurrent.com/trials/a-study-for-participants-with-small-cell-lung-cancer-50475 https://curecurrent.com/trials/outcomes-of-surgical-resection-after-induction-treatment-in-non-small-cell-lung-cancer-srait-50476 https://curecurrent.com/trials/ngr015-study-in-second-line-for-patient-with-advanced-malignant-pleural-mesothelioma-pretreated-with-pemetrexed-50477 https://curecurrent.com/trials/kpt-330-to-treat-poorly-differentiated-lung-and-gastroenteropancreatic-tumors-50478 https://curecurrent.com/trials/safety-and-efficacy-of-crizotinib-regulatory-post-marketing-commitment-plan-50479 https://curecurrent.com/trials/a-study-of-pemetrexed-and-carboplatin-cisplatin-or-gemcitabine-and-carboplatin-cisplatin-with-or-without-imc-1121b-in-pa-50480 https://curecurrent.com/trials/feasibility-study-of-a-nurse-intervention-to-impact-mucositis-severity-and-prevent-dehydration-50481 https://curecurrent.com/trials/safety-and-efficiency-of-t-cell-against-non-small-lung-cancer-without-egfr-mutation-50482 https://curecurrent.com/trials/combination-of-cryosurgery-and-nk-immunotherapy-for-advanced-non-small-cell-lung-cancer-50483 https://curecurrent.com/trials/pembrolizumab-alone-and-in-combination-with-acalabrutinib-acp-196-in-subjects-with-advanced-non-small-cell-lung-cancer-50484 https://curecurrent.com/trials/randomized-phase-iii-trial-of-surgery-alone-or-surgery-plus-preoperative-gemcitabine-cisplatin-in-early-stages-nsclc-50485 https://curecurrent.com/trials/combination-of-cetuximab-and-nk-immunotherapy-for-recurrent-non-small-cell-lung-cancer-50486 https://curecurrent.com/trials/high-activity-natural-killer-immunotherapy-for-small-metastases-of-non-small-cell-lung-cancer-50487 https://curecurrent.com/trials/the-immunotherapy-of-nasopharyngeal-cancer-using-cancer-stem-cells-vaccine-50488 https://curecurrent.com/trials/a-randomized-phase-3-trial-of-pemetrexed-and-cisplatin-versus-gemcitabine-and-cisplatin-in-patients-with-locally-advance-50489 https://curecurrent.com/trials/a-comparison-of-two-doses-of-pemetrexed-in-patients-who-have-lung-cancer-50490 https://curecurrent.com/trials/hsp90-inhibitor-auy922-and-erlotinib-hydrochloride-in-treating-patients-with-stage-iiib-iv-non-small-cell-lung-cancer-50491 https://curecurrent.com/trials/study-of-ly2181308-in-combination-with-docetaxel-versus-docetaxel-in-patients-with-non-small-cell-lung-cancer-50492 https://curecurrent.com/trials/olympus-19-gauge-needle-50493 https://curecurrent.com/trials/a-study-of-pemetrexed-and-gefitinib-versus-gefitinib-in-non-small-cell-lung-cancer-nsclc-50494 https://curecurrent.com/trials/expanded-access-to-rovalpituzumab-tesirine-50495 https://curecurrent.com/trials/safety-efficacy-study-of-egf-cancer-vaccine-to-treat-stage-iv-biomarker-positive-wild-type-egf-r-nsclc-patients-50496 https://curecurrent.com/trials/bronchoscopy-with-bronchoalveolar-lavage-in-identifying-biomarkers-of-response-to-immune-checkpoint-inhibitors-in-patien-50497 https://curecurrent.com/trials/study-of-kn046-with-chemotherapy-in-first-line-advanced-nsclc-50498 https://curecurrent.com/trials/study-of-nivolumab-in-combination-with-gm-cd40l-vaccine-in-adenocarcinoma-of-the-lung-50499 https://curecurrent.com/trials/erlotinib-or-placebo-following-chemoradiotherapy-chemo-rt-in-stage-iii-non-small-cell-lung-cancer-nsclc-50500 https://curecurrent.com/trials/microbiome-in-pulmonary-tuberculosis-non-tuberculous-mycobacterial-pulmonary-diseases-lung-cancer-and-hemoptysis-50501 https://curecurrent.com/trials/photon-versus-particle-therapy-for-recurrent-lung-cancer-a-planning-study-based-on-a-reference-dataset-of-patients-50502 https://curecurrent.com/trials/a-multi-center-trial-of-the-prolung-test-50503 https://curecurrent.com/trials/ct-screening-for-lung-cancer-in-high-risk-patients-the-russian-study-50504 https://curecurrent.com/trials/genetic-sequencing-informed-targeted-therapy-in-treating-patients-with-stage-iiib-iv-non-small-cell-lung-cancer-50505 https://curecurrent.com/trials/atovaquone-as-tumour-hypoxia-modifier-50506 https://curecurrent.com/trials/evolution-of-corporeal-composition-in-the-perioperative-period-50507 https://curecurrent.com/trials/study-of-anlotinib-hydrochloride-capsule-in-subjects-with-small-cell-lung-cancer-50508 https://curecurrent.com/trials/low-dose-computed-tomography-for-lung-cancer-screening-50509 https://curecurrent.com/trials/study-of-anlotinib-hydrochloride-capsule-combined-with-chemotherapy-in-subjects-with-squamous-non-small-cell-lung-cancer-50510 https://curecurrent.com/trials/to-evaluate-the-qol-improvement-of-oral-oligo-fucoidan-in-subjects-receiving-platinum-based-chemotherapy-with-nsclc-50511 https://curecurrent.com/trials/a-study-to-demonstrate-the-benefit-of-a-new-kind-of-anti-cancer-treatment-preferentially-expressed-antigen-of-melanoma-p-50512 https://curecurrent.com/trials/assessing-safety-and-efficacy-of-sintilimab-and-metformin-combination-therapy-in-sclc-50513 https://curecurrent.com/trials/phase-3-trial-in-squamous-non-small-cell-lung-cancer-subjects-comparing-ipilimumab-plus-paclitaxel-and-carboplatin-versu-50514 https://curecurrent.com/trials/liquid-biopsy-in-lung-cancer-50515 https://curecurrent.com/trials/a-trial-of-amg-479-everolimus-rad001-and-panitumumab-in-patients-with-advanced-cancer-quilt-3-007-50516 https://curecurrent.com/trials/prediction-model-for-multiple-pulmonary-nodules-50517 https://curecurrent.com/trials/olmutinib-trial-in-t790m-nsclc-patients-detected-by-liquid-biopsy-using-balf-extracellular-vesicular-dna-50518 https://curecurrent.com/trials/understanding-evidence-based-practice-patterns-in-advanced-nsclc-50519 https://curecurrent.com/trials/identifying-genomic-mutations-of-multiple-primary-lung-cancers-by-circulating-tumor-dna-50520 https://curecurrent.com/trials/18-f-faza-pet-imaging-study-in-patients-with-cancer-of-the-head-neck-lung-renal-cell-brain-lymphoma-and-neuroendocrine-t-50521 https://curecurrent.com/trials/real-world-study-on-adjuvant-therapy-combined-with-shenlingcao-oral-liquid-in-patients-for-stage-ii-and-iiia-non-small-c-50522 https://curecurrent.com/trials/cisplatin-irinotecan-with-concurrent-radiation-for-inoperable-nsclc-50523 https://curecurrent.com/trials/effect-of-magnesium-sulphate-infusion-on-lung-mechanics-and-oxygenation-in-copd-patients-undergoing-total-laryngeal-50524 https://curecurrent.com/trials/detection-of-circulating-biomarkers-of-immunogenic-cell-death-50525 https://curecurrent.com/trials/study-of-anlotinib-combined-with-osimertinib-as-second-line-treatment-in-stage-iiib-iv-nsclc-with-confirmed-egfrm-and-t7-50526 https://curecurrent.com/trials/endostar-pd-1-inhibitors-combined-with-pp-for-advanced-nsclc-50527 https://curecurrent.com/trials/pulmonary-nodule-detection-comparison-of-an-ultra-low-dose-vs-standard-scan-50528 https://curecurrent.com/trials/phase-2-study-of-pyrotinib-in-previously-treated-patients-with-nsclc-having-egfr-or-erbb2-exon-20-insertion-mutation-50529 https://curecurrent.com/trials/curative-proton-beam-therapy-for-patients-with-lung-metastasis-of-colorectal-cancer-50530 https://curecurrent.com/trials/treating-nsclc-minimal-stage-iv-with-curative-intent-50531 https://curecurrent.com/trials/evaluation-of-the-impact-of-a-coordinating-nurse-in-a-personalized-care-program-on-quality-of-care-coordination-of-the-a-50532 https://curecurrent.com/trials/study-to-evaluate-gsk3052230-in-combination-with-paclitaxel-and-carboplatin-or-docetaxel-or-as-single-agent-in-subjects-50533 https://curecurrent.com/trials/dynamic-magnetic-resonance-imaging-mri-for-lung-tumor-motion-and-lung-function-gcc-0943-50534 https://curecurrent.com/trials/treatment-of-non-small-cell-lung-cancer-with-pd-1-monoclonal-antibody-combined-with-donafenib-toluene-sulfonate-50535 https://curecurrent.com/trials/effect-of-qigong-therapy-in-patients-with-advanced-lung-and-gastrointestinal-cancer-undergoing-chemotherapy-50536 https://curecurrent.com/trials/safety-and-efficacy-study-of-tq-b3101-in-patients-with-ros1-positive-non-small-cell-lung-cancer-nsclc-50537 https://curecurrent.com/trials/study-of-tqb2450-combined-with-anlotinib-in-the-treatment-of-mutation-positive-lung-cancer-50538 https://curecurrent.com/trials/a-study-to-determine-the-efficiency-for-brain-metastasis-nsclc-patients-treated-with-icotinib-alone-or-combined-with-rad-50539 https://curecurrent.com/trials/measure-of-plasma-tissue-factor-to-predict-a-venous-thromboembolism-in-primitive-cancer-of-lung-50540 https://curecurrent.com/trials/can-a-pulmonologist-reliably-assess-the-tumor-burden-on-rose-slides-obtained-from-pulmonary-nodules-and-lymphadenopathy-50541 https://curecurrent.com/trials/efficacy-and-safety-of-ibi308-and-paclitaxel-albumin-paclitaxel-for-sclc-patients-who-failed-etoposide-chemotherapy-50542 https://curecurrent.com/trials/3d-printing-for-nodule-localization-50543 https://curecurrent.com/trials/tiger-3-open-label-multicenter-study-of-rociletinib-co-1686-mono-therapy-versus-single-agent-cytotoxic-chemotherapy-in-p-50544 https://curecurrent.com/trials/the-safety-and-efficacy-of-pemetrexed-rechallenge-with-bevacizumab-50545 https://curecurrent.com/trials/study-of-the-safety-and-activity-of-lenvatinib-e7080-in-subjects-with-kif5b-ret-positive-adenocarcinoma-of-the-lung-50546 https://curecurrent.com/trials/oncolytic-adenovirus-mediated-gene-therapy-for-lung-cancer-50547 https://curecurrent.com/trials/afatinib-bibw-2992-in-advanced-non-small-cell-lung-cancer-patients-with-egfr-mutation-50548 https://curecurrent.com/trials/reducing-insulin-growth-hormones-and-tumors-50549 https://curecurrent.com/trials/study-of-bms-986012-in-subjects-with-small-cell-lung-caner-50550 https://curecurrent.com/trials/evaluation-of-a-multi-professional-breathlessness-service-for-patients-with-breathlessness-due-to-any-advanced-disease-50551 https://curecurrent.com/trials/prospective-study-on-the-treatment-of-unsuspected-pulmonary-embolism-in-cancer-patients-50552 https://curecurrent.com/trials/pulmonary-nodule-cohort-50553 https://curecurrent.com/trials/prospective-analysis-of-robot-assisted-surgery-50554 https://curecurrent.com/trials/real-world-data-on-gi-l-otrif-dose-adjustment-50555 https://curecurrent.com/trials/risk-adapted-sabr-sabr-in-stage-i-nsclc-and-lung-metastases-50556 https://curecurrent.com/trials/phase-2-study-of-inhaled-lipid-cisplatin-in-pulmonary-recurrent-osteosarcoma-50557 https://curecurrent.com/trials/erlotinib-hydrochloride-with-or-without-carboplatin-and-paclitaxel-in-treating-patients-with-stage-iii-iv-non-small-cell-50558 https://curecurrent.com/trials/re-directed-t-cells-for-the-treatment-fap-positive-malignant-pleural-mesothelioma-50559 https://curecurrent.com/trials/a-study-of-trastuzumab-emtansine-in-participants-with-human-epidermal-growth-factor-receptor-her-2-immunohistochemistry-50560 https://curecurrent.com/trials/combination-immunotherapy-of-gm-cd40l-vaccine-with-ccl21-in-lung-cancer-50561 https://curecurrent.com/trials/circulating-dna-in-surgically-treated-nsclc-50562 https://curecurrent.com/trials/erlotinib-hydrochloride-or-crizotinib-and-chemoradiation-therapy-in-treating-patients-with-stage-iii-non-small-cell-lung-50563 https://curecurrent.com/trials/consolidation-treatment-with-ponatinib-15-mg-on-treatment-free-remission-rate-in-patients-with-chronic-myeloid-leukemia-50564 https://curecurrent.com/trials/the-efficacy-of-pd-1-antibody-sintilimab-on-early-stage-multiple-primary-lung-cancer-with-ground-glass-density-50565 https://curecurrent.com/trials/evaluate-egfr-mutation-status-and-impact-factors-in-north-china-50566 https://curecurrent.com/trials/immune-modulated-study-of-selected-small-molecules-gefitinib-azd9291-or-selumetinib-docetaxel-or-a-1st-immune-mediated-t-50567 https://curecurrent.com/trials/palliative-thoracic-radiotherapy-plus-bkm120-50568 https://curecurrent.com/trials/a-real-world-study-to-explore-recurrence-metastases-of-the-nsclc-patients-and-the-impact-factors-of-patient-survivals-50569 https://curecurrent.com/trials/the-affection-of-two-chest-management-for-enhanced-recovery-program-after-video-assisted-thoracoscopic-lobectomy-50570 https://curecurrent.com/trials/a-phase-i-ii-trial-of-stereotactic-body-radiation-therapy-50571 https://curecurrent.com/trials/cancer-development-in-organ-transplant-recipients-50572 https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-the-vegfr-fgfr-inhibitor-lucitanib-given-to-patients-with-advanced-metastat-50573 https://curecurrent.com/trials/clinical-and-pathophysiological-investigations-into-erdheim-chester-disease-50574 https://curecurrent.com/trials/a-study-to-investigate-the-food-effect-on-the-pharmacokinetics-of-ensartinib-capsules-in-chinese-healthy-volunteers-50575 https://curecurrent.com/trials/bioequivalency-study-of-ensartinib-capsules-in-healthy-volunteers-50576 https://curecurrent.com/trials/an-open-label-randomized-phase-ii-study-to-evaluate-the-efficacy-of-auy922-vs-pemetrexed-or-docetaxel-in-nsclc-patients-50577 https://curecurrent.com/trials/an-observational-post-authorisation-study-to-evaluate-safety-and-efficacy-in-patients-receiving-azacitidine-in-daily-cli-50578 https://curecurrent.com/trials/acupuncture-feasibility-trial-for-dyspnea-in-lung-cancer-50579 https://curecurrent.com/trials/evaluation-of-use-of-diagnostic-ai-for-lung-cancer-in-practice-50580 https://curecurrent.com/trials/a-study-to-assess-programmed-death-ligand-1-pd-l1-expression-in-cytological-versus-histological-lung-cancer-specimens-50581 https://curecurrent.com/trials/a-study-of-ly2510924-in-participants-with-extensive-stage-small-cell-lung-carcinoma-50582 https://curecurrent.com/trials/phase-i-study-of-tetrathiomolybdate-in-combination-with-carboplatin-pemetrexed-in-metastatic-non-small-cell-lung-cancer-50583 https://curecurrent.com/trials/retrospective-epidemiology-study-of-alk-rearrangement-in-non-small-cell-lung-cancer-patients-in-the-middle-east-north-af-50584 https://curecurrent.com/trials/genomic-landscape-of-egfr-mutant-nsclc-prior-to-erlotinib-and-at-the-time-of-disease-progression-50585 https://curecurrent.com/trials/inhaled-steroids-for-pediatric-asthma-at-pediatric-emergency-medicine-discharge-50586 https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetic-profile-of-bpi-15086-in-egfr-t790m-mutation-positive-nsclc-patients-50587 https://curecurrent.com/trials/a-study-of-nivolumab-docetaxel-in-patients-previously-treated-with-advanced-or-metastatic-nsclc-50588 https://curecurrent.com/trials/quantification-of-micrornas-in-diagnosis-of-pulmonary-nodules-50589 https://curecurrent.com/trials/study-of-glembatumumab-vedotin-in-gpnmb-expressing-advanced-or-metastatic-scc-of-the-lung-50590 https://curecurrent.com/trials/19f-thoracic-radiotherapy-for-lung-cancer-50591 https://curecurrent.com/trials/mechanically-assisted-ventilation-in-the-treatment-of-moving-tumours-with-photon-and-proton-therapies-50592 https://curecurrent.com/trials/a-study-to-determine-the-feasibility-and-acceptability-of-conducting-a-phase-iii-randomised-controlled-trial-comparing-s-50593 https://curecurrent.com/trials/early-palliative-care-in-metastatic-lung-cancer-in-northern-france-50594 https://curecurrent.com/trials/magnetic-resonance-imaging-mri-for-the-delineation-of-organs-at-risk-oar-and-target-volumes-in-lung-cancer-patients-50595 https://curecurrent.com/trials/haploidentical-nk-cells-after-pemetrexed-in-patients-with-stage-iv-non-small-cell-lung-cancer-nsclc-50596 https://curecurrent.com/trials/exercise-intervention-during-chemotherapy-in-advanced-lung-cancer-patients-50597 https://curecurrent.com/trials/wholebody-mri-in-lung-cancer-staging-50598 https://curecurrent.com/trials/anlotinib-hydrochloride-combined-with-egfr-tyrosine-kinase-inhibitor-tki-in-treating-advanced-nsclc-patients-with-acquir-50599 https://curecurrent.com/trials/inflammatory-response-after-one-lung-ventilation-according-to-ventilation-methods-50600 https://curecurrent.com/trials/inpatient-smokers-and-ldct-screening-rct-50601 https://curecurrent.com/trials/effect-of-dexmedetomidine-on-the-inflammatory-response-after-one-lung-ventilation-50602 https://curecurrent.com/trials/a-phase-1b-2-study-of-safety-and-efficacy-of-rociletinib-in-combination-with-mpdl3280a-in-patients-with-advanced-or-meta-50603 https://curecurrent.com/trials/overall-survival-of-large-cell-neuroendocrine-lung-cancer-patients-a-retrospective-study-50604 https://curecurrent.com/trials/physical-impairments-related-to-myeloid-and-lymphoid-malignancies-50605 https://curecurrent.com/trials/crizotinib-plus-pembrolizumab-in-alk-positive-advanced-non-small-cell-lung-cancer-patients-50606 https://curecurrent.com/trials/combined-cfrt-and-sabr-in-stage-ii-and-iii-nsclc-with-peripheral-tumors-smaller-than-5-cm-50607 https://curecurrent.com/trials/irradiation-of-large-lung-tumors-or-two-or-more-lung-metastases-simultaneously-50608 https://curecurrent.com/trials/alisertib-mln8237-in-combination-with-weekly-paclitaxel-in-east-asian-patients-with-advanced-solid-tumors-50609 https://curecurrent.com/trials/effects-of-vns-on-rt-induced-inflammation-and-prognosis-of-patients-with-nsclc-50610 https://curecurrent.com/trials/bortezomib-ps-341-in-combination-with-carboplatin-and-docetaxel-for-patients-with-advanced-non-small-cell-lung-cancer-50611 https://curecurrent.com/trials/comparison-of-iv-topotecan-docetaxel-to-docetaxel-alone-in-second-line-stage-iiib-iv-non-small-cell-lung-cancer-50612 https://curecurrent.com/trials/clinical-study-of-combination-therapy-with-ectiecinib-pemetrexed-and-platinum-in-patients-with-metastatic-non-squamous-n-50613 https://curecurrent.com/trials/expression-analysis-of-specific-markers-in-non-small-cell-lung-cancer-or-melanoma-50614 https://curecurrent.com/trials/methods-of-computed-tomography-screening-and-management-of-lung-cancer-50615 https://curecurrent.com/trials/efficacy-study-of-vx001-vaccine-in-nsclc-patients-50616 https://curecurrent.com/trials/computed-tomography-screening-for-early-lung-cancer-copd-and-cardiovascular-disease-in-shanghai-china-50617 https://curecurrent.com/trials/study-of-chemotherapy-combination-with-autologous-cell-immunotherapy-in-the-advanced-lung-cancer-50618 https://curecurrent.com/trials/a-randomized-study-of-primary-tumor-radiotherapy-for-patients-with-mpe-stage-iv-nsclc-50619 https://curecurrent.com/trials/malignant-mesothelioma-can-we-improve-quality-of-life-50620 https://curecurrent.com/trials/nivolumab-and-epacadostat-with-platinum-doublet-chemotherapy-versus-platinum-doublet-chemotherapy-in-non-small-cell-lung-50621 https://curecurrent.com/trials/efficacy-study-of-comprehensive-rehabilitation-program-plus-chemotherapy-in-postoperative-nsclc-patients-50622 https://curecurrent.com/trials/evaluation-in-real-world-of-molecular-testing-and-treatment-patterns-for-egfr-mutation-in-lung-cancer-patients-50623 https://curecurrent.com/trials/efficacy-study-of-comprehensive-rehabilitation-program-in-postoperative-nsclc-patients-50624 https://curecurrent.com/trials/adjuvant-chemotherapy-with-or-without-intercalated-icotinib-50625 https://curecurrent.com/trials/pathos-study-pain-assessment-in-thoracic-oncologic-surgery-50626 https://curecurrent.com/trials/anlotinib-combined-with-docetaxel-versus-docetaxel-for-previous-treated-advanced-nsclc-50627 https://curecurrent.com/trials/ss1p-and-pentostatin-plus-cyclophosphamide-for-mesothelioma-50628 https://curecurrent.com/trials/oncoxin-and-quality-of-life-in-cancer-patients-50629 https://curecurrent.com/trials/study-of-thalidomide-in-treatment-of-advanced-nsclc-dream-003-50630 https://curecurrent.com/trials/cbct-in-guiding-bronchoscopy-in-patients-with-lung-lesions-50631 https://curecurrent.com/trials/comparison-of-diagnostic-and-therapeutic-efficacy-of-ebus-tbna-eus-fna-and-temla-in-operable-nsclc-50632 https://curecurrent.com/trials/the-role-of-microbiota-on-the-development-of-lung-cancer-50633 https://curecurrent.com/trials/pd-1-inhibitors-consolidation-in-extensive-stage-small-cell-lung-cancer-50634 https://curecurrent.com/trials/gene-polymorphisms-and-symptoms-in-lung-cancer-patients-50635 https://curecurrent.com/trials/carboplatin-pemetrexed-disodium-and-bevacizumab-in-treating-patients-with-stage-iiib-stage-iv-or-recurrent-non-small-cel-50636 https://curecurrent.com/trials/low-dose-protocol-for-computed-tomography-guided-lung-biopsy-50637 https://curecurrent.com/trials/neck-ultrasound-by-respiratory-physicians-in-patients-with-lung-cancer-50638 https://curecurrent.com/trials/pneumoperitoneum-management-with-low-vs-higher-pressure-50639 https://curecurrent.com/trials/folate-one-carbon-malnutrition-as-the-metabostemness-risk-factor-of-malignancy-tumor-development-of-nsclc-patients-50640 https://curecurrent.com/trials/g-csf-and-pegfilgrastim-in-treating-neutropenia-in-patients-undergoing-radiation-therapy-and-chemotherapy-for-limited-st-50641 https://curecurrent.com/trials/ifct-gfpc-05-02-a-randomized-phase-iii-trial-assessing-in-patients-with-advanced-non-small-cell-lung-cancer-50642 https://curecurrent.com/trials/three-modalities-of-treatment-in-operable-and-resectable-stage-iiia-t1-3-n2-non-small-cell-lung-cancer-nsclc-50643 https://curecurrent.com/trials/an-observational-study-of-cpt-11-plus-platinum-analogues-regimens-and-ugt1a1-genotypes-in-solid-tumors-50644 https://curecurrent.com/trials/nm404-as-an-imaging-agent-in-patients-with-nsclc-50645 https://curecurrent.com/trials/anti-mesothelin-antibody-drug-conjugate-anetumab-ravtansine-for-mesothelin-expressing-lung-adenocarcinoma-50646 https://curecurrent.com/trials/nse-alb-as-a-prognostic-biomarker-for-lung-cancer-50647 https://curecurrent.com/trials/pf-00299804-as-a-single-agent-in-patients-with-advanced-non-small-cell-lung-cancer-who-have-failed-chemotherapy-and-erlo-50648 https://curecurrent.com/trials/ct-guided-radioactive-i-125-seeds-implantation-for-early-stage-lung-cancer-50649 https://curecurrent.com/trials/nivolumab-in-treating-patients-with-advanced-metastatic-non-small-cell-lung-cancer-50650 https://curecurrent.com/trials/clinical-significance-of-computer-aided-image-analysis-in-treatment-response-evaluation-of-lung-cancer-50651 https://curecurrent.com/trials/concordance-of-inivata-liquid-biopsy-with-standard-of-care-tissue-testing-50652 https://curecurrent.com/trials/cabozantinib-s-malate-and-erlotinib-hydrochloride-in-treating-patients-with-previously-treated-metastatic-non-small-cell-50653 https://curecurrent.com/trials/concordance-of-inivata-liquid-biopsy-with-standard-tissue-biopsy-50654 https://curecurrent.com/trials/study-of-anlotinib-in-patients-with-small-cell-lung-cancer-alter1202-50655 https://curecurrent.com/trials/bevacizumab-and-erlotinib-followed-by-cisplatin-or-carboplatin-and-gemcitabine-in-treating-patients-with-newly-diagnosed-50656 https://curecurrent.com/trials/six-minute-walk-test-in-patients-at-high-risk-for-complications-from-lung-resection-50657 https://curecurrent.com/trials/bevacizumab-pemetrexed-disodium-and-cisplatin-or-erlotinib-hydrochloride-and-bevacizumab-in-treating-patients-with-stage-50658 https://curecurrent.com/trials/pemetrexed-disodium-and-cisplatin-followed-by-surgery-with-or-without-radiation-therapy-in-treating-patients-with-malign-50659 https://curecurrent.com/trials/battle-fl-front-line-biomarker-integrated-treatment-study-in-non-small-cell-lung-cancer-50660 https://curecurrent.com/trials/k-ras-and-egfr-in-lung-cancer-50661 https://curecurrent.com/trials/combination-chemotherapy-followed-by-surgery-in-treating-patients-with-non-small-cell-lung-cancer-50662 https://curecurrent.com/trials/combination-chemotherapy-followed-by-radiation-therapy-before-surgery-in-treating-patients-with-stage-iiib-nsclc-50663 https://curecurrent.com/trials/dexamethasone-for-treatment-of-radiation-related-fatigue-in-patients-receiving-rt-for-head-neck-and-lung-cancer-50664 https://curecurrent.com/trials/the-wessex-fit-4-cancer-surgery-trial-50665 https://curecurrent.com/trials/azacitidine-and-entinostat-in-treating-patients-with-recurrent-advanced-non-small-cell-lung-cancer-50666 https://curecurrent.com/trials/radiofrequency-ablation-and-external-beam-radiation-therapy-in-treating-patients-with-stage-i-non-small-cell-lung-cancer-50667 https://curecurrent.com/trials/efficacy-and-safety-of-omega-3-fatty-acid-supplements-on-heavy-smokers-50668 https://curecurrent.com/trials/erector-spinae-plane-block-for-postoperative-analgesia-management-following-video-assisted-thoracic-surgery-50669 https://curecurrent.com/trials/exemestane-pemetrexed-disodium-and-carboplatin-in-treating-post-menopausal-women-with-stage-iv-non-small-cell-lung-cance-50670 https://curecurrent.com/trials/anlotinib-therapy-in-patients-with-advanced-lung-cancer-50671 https://curecurrent.com/trials/tiger-1-safety-and-efficacy-study-of-rociletinib-co-1686-or-erlotinib-in-patients-with-egfr-mutant-metastatic-nsclc-who-50672 https://curecurrent.com/trials/assessment-of-patient-frailty-prior-to-thoracic-surgery-50673 https://curecurrent.com/trials/18fdg-pet-in-patients-with-melanoma-or-nsclc-treated-with-immunotherapy-50674 https://curecurrent.com/trials/zoledronic-acid-in-decrease-the-lung-metastatic-rate-of-osteosarcoma-50675 https://curecurrent.com/trials/self-management-intervention-for-breathlessness-in-lung-cancer-50676 https://curecurrent.com/trials/stereotactic-body-radiotherapy-and-radiofrequency-ablation-for-lung-tumors-near-central-airways-50677 https://curecurrent.com/trials/evaluating-mutations-in-met-and-tp53-among-patients-diagnosed-with-squamous-cell-carcinoma-50678 https://curecurrent.com/trials/the-effect-of-iloprost-on-oxygenation-during-one-lung-ventilation-for-lung-surgery-50679 https://curecurrent.com/trials/a-phase-i-dose-escalation-study-of-erlotinib-in-combination-with-theophylline-50680 https://curecurrent.com/trials/pet-ct-directed-hyperfractionated-radiation-dose-escalation-in-stage-iii-non-small-cell-lung-cancer-50681 https://curecurrent.com/trials/microarray-analysis-of-gene-expression-and-identification-of-progenitor-cells-in-lung-carcinoma-50682 https://curecurrent.com/trials/pemetrexed-disodium-and-gemcitabine-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-50683 https://curecurrent.com/trials/efficacy-study-of-long-term-parenteral-nutrition-with-smofkabiven-e-in-lung-cancer-patients-under-anticancer-therapy-50684 https://curecurrent.com/trials/stereotactic-body-radiation-therapy-in-treating-patients-with-stage-i-or-stage-ii-non-small-cell-lung-cancer-that-can-be-50685 https://curecurrent.com/trials/docetaxel-versus-intercalated-erlotinib-docetaxel-in-patients-with-relapsed-egfr-wild-type-alk-negative-non-squamous-cel-50686 https://curecurrent.com/trials/the-attain-study-a-therapeutic-trial-of-afatinib-in-the-neoadjuvant-setting-50687 https://curecurrent.com/trials/efficacy-of-flutiform-vs-seretide-in-moderate-to-severe-persistent-asthma-in-subjects-aged-12-years-50688 https://curecurrent.com/trials/role-of-spect-in-radiotherapy-of-lung-cancer-and-toxicity-evaluation-50689 https://curecurrent.com/trials/oral-immunomodulatory-tyrosine-kinase-inhibitor-in-patients-with-locally-advanced-or-metastatic-solid-tumors-50690 https://curecurrent.com/trials/study-of-rxdx-105-potent-ret-inhibitor-in-patients-with-advanced-lung-cancer-and-other-solid-tumors-50691 https://curecurrent.com/trials/monitoring-and-telecoaching-of-physical-activity-in-patients-with-stage-iii-and-iv-non-small-cell-lung-cancer-50692 https://curecurrent.com/trials/pazopanib-in-patients-with-relapsed-or-refractory-small-cell-lung-cancer-50693 https://curecurrent.com/trials/maintenance-low-dose-oral-navelbine-in-patients-with-non-small-cell-lung-cancer-ma-ni-la-trial-50694 https://curecurrent.com/trials/immune-checkpoint-inhibitors-and-pre-existing-autoimmune-diseases-50695 https://curecurrent.com/trials/biomarker-study-accompanying-the-aio-trk-0114-study-marble-50696 https://curecurrent.com/trials/impact-of-smoking-information-on-concerns-about-radon-50697 https://curecurrent.com/trials/a-study-of-dabigatran-etexilate-as-primary-treatment-of-malignancy-associated-venous-thromboembolism-50698 https://curecurrent.com/trials/tki-followed-by-thoracic-radiotherapy-for-stage-iv-egfr-mutant-nsclc-50699 https://curecurrent.com/trials/atezolizumab-in-combination-with-bevacizumab-carboplatin-and-pemetrexed-for-egfr-mutant-metastatic-nsclc-patients-after-50700 https://curecurrent.com/trials/hs-pci-in-locally-advanced-adenocarcinoma-of-the-lung-50701 https://curecurrent.com/trials/a-series-of-study-in-testing-efficacy-of-pulmonary-rehabilitation-interventions-in-lung-cancer-survivors-50702 https://curecurrent.com/trials/study-of-autologous-tumor-infiltrating-lymphocytes-ln-145-in-combo-with-durvalumab-in-non-small-cell-lung-cancer-50703 https://curecurrent.com/trials/effectiveness-of-bronchoscopic-interventions-for-malignant-airway-obstruction-50704 https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-cp-690-550-in-asian-subjects-with-moderate-to-severe-plaque-psoriasis-50705 https://curecurrent.com/trials/study-of-hsp90-inhibitor-sta-9090-for-relapsed-or-refractory-small-cell-lung-cancer-50706 https://curecurrent.com/trials/clinical-study-of-chinese-medicine-plus-chemotherapy-maintenance-in-advanced-non-small-cell-lung-cancer-50707 https://curecurrent.com/trials/immunization-of-patients-with-non-small-cell-lung-cancer-nsclc-50708 https://curecurrent.com/trials/imrt-combined-with-erlotinib-for-egfr-wild-type-non-small-cell-lung-cancer-with-4-10-brain-metastases-50709 https://curecurrent.com/trials/perfusion-induced-hyperthermia-for-metastatic-carcinoma-50710 https://curecurrent.com/trials/personalized-therapeutic-anti-tumor-vaccine-with-pembrolizumab-and-standard-of-care-chemotherapy-in-squamous-non-small-c-50711 https://curecurrent.com/trials/pioglitazone-for-lung-cancer-chemoprevention-50712 https://curecurrent.com/trials/clinical-study-of-chinese-medicine-plus-targeted-therapy-maintenance-in-advanced-pulmonary-adenocarcinoma-50713 https://curecurrent.com/trials/clinical-study-of-yyjd-decoction-combined-with-gefitinib-in-advanced-pulmonary-adenocarcinoma-50714 https://curecurrent.com/trials/cabozantinib-in-non-small-cell-lung-cancer-nsclc-patients-with-met-deregulation-50715 https://curecurrent.com/trials/in-hospital-physiotherapy-for-patients-undergoing-thoracic-surgery-a-randomized-controlled-trial-50716 https://curecurrent.com/trials/care-coordination-in-oncology-quality-among-patients-with-lung-cancer-and-their-caregivers-50717 https://curecurrent.com/trials/move-for-surgery-mfs-evaluating-the-use-of-wearable-technology-for-preconditioning-before-thoracic-surgery-50718 https://curecurrent.com/trials/bevacizumab-and-radiotherapy-for-oligometastasis-of-lung-adenocarcinoma-with-negative-driver-gene-50719 https://curecurrent.com/trials/oral-green-tea-extract-for-small-cell-lung-cancer-50720 https://curecurrent.com/trials/pet-ct-based-radiomics-for-lung-cancer-perl-50721 https://curecurrent.com/trials/comparable-study-of-different-thoracic-radiotherapy-regimens-for-extensive-stage-small-cell-lung-cancer-50722 https://curecurrent.com/trials/apatinib-combined-with-egfr-tki-for-advanced-slow-progressed-egfr-tki-resistant-nsclc-50723 https://curecurrent.com/trials/a-study-of-anti-pd1-antibody-activated-tils-in-non-small-cell-lung-cancer-50724 https://curecurrent.com/trials/awake-thoracic-epidural-anaesthesia-versus-general-anesthesia-for-video-assisted-thoracoscopic-surgery-50725 https://curecurrent.com/trials/evaluation-of-crs-207-with-pembrolizumab-in-previously-treated-malignant-pleural-mesothelioma-mpm-50726 https://curecurrent.com/trials/development-and-feasibility-testing-of-a-lung-cancer-screening-decision-aid-50727 https://curecurrent.com/trials/canpos-predictive-biomarkers-of-tumor-progression-in-non-small-cell-lung-cancer-50728 https://curecurrent.com/trials/the-impact-of-intraoperative-systemic-lidocaine-infusion-on-chronic-postoperative-pain-after-video-assisted-thoracic-sur-50729 https://curecurrent.com/trials/intrapleural-bevacizumab-injection-for-malignant-effusion-in-lung-cancer-50730 https://curecurrent.com/trials/phase-i-study-of-the-combination-of-afatinib-and-ruxolitinib-in-patients-with-treatment-refractory-non-small-cell-lung-c-50731 https://curecurrent.com/trials/eicosanoid-lipids-by-airway-cells-during-infection-with-human-rhinoviruses-50732 https://curecurrent.com/trials/temozolomide-in-preventing-brain-metastases-in-small-cell-lung-cancer-50733 https://curecurrent.com/trials/screening-for-lung-cancer-in-the-hiv-patient-50734 https://curecurrent.com/trials/anlotinib-combined-with-etoposide-and-platinum-in-the-treatment-of-lung-cancer-50735 https://curecurrent.com/trials/pemetrexed-cisplatin-intercalating-gefitinib-treating-egfr-wild-nsclc-50736 https://curecurrent.com/trials/effects-of-intraoperative-continuous-airway-pressure-cpap-on-the-inflammatory-response-to-one-lung-ventilation-50737 https://curecurrent.com/trials/bevacizumab-and-docetaxel-in-treating-older-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-cancer-50738 https://curecurrent.com/trials/clinical-study-of-first-line-treatment-of-small-cell-lung-cancer-sclc-with-anlotinib-hydrochloride-50739 https://curecurrent.com/trials/vandetanib-carboplatin-and-paclitaxel-in-treating-patients-with-stage-i-stage-ii-or-stage-iii-non-small-cell-lung-cancer-50740 https://curecurrent.com/trials/abscopal-effect-for-metastatic-non-small-cell-lung-cancer-50741 https://curecurrent.com/trials/a-phase-i-iia-open-label-dose-escalation-and-cohort-expansion-trial-of-oral-tsr-011-in-patients-with-advanced-solid-tumo-50742 https://curecurrent.com/trials/prevention-of-locally-advanced-nsclc-radiotherapy-pneumonia-by-inhaling-beclomethasone-propionate-50743 https://curecurrent.com/trials/ldk378-in-crizotinib-na-ve-adult-patients-with-alk-activated-non-small-cell-lung-cancer-50744 https://curecurrent.com/trials/sdc-for-lung-cancer-patients-treated-with-curative-primary-or-postoperative-radiotherapy-or-chemoradiation-50745 https://curecurrent.com/trials/bnp-for-prediction-of-outcome-following-lung-resection-surgery-50746 https://curecurrent.com/trials/evaluation-of-endobronchial-ultrasound-ebus-for-staging-lung-cancer-50747 https://curecurrent.com/trials/photodynamic-therapy-during-surgery-in-treating-patients-with-pleural-malignancy-50748 https://curecurrent.com/trials/consolidation-sintilimab-after-concurrent-chemoradiation-in-patients-with-unresectable-stage-iii-nsclc-50749 https://curecurrent.com/trials/abscopal-effect-for-metastatic-small-cell-lung-cancer-50750 https://curecurrent.com/trials/improving-communication-about-serious-illness-50751 https://curecurrent.com/trials/carboplatin-bevacizumab-and-pemetrexed-in-advanced-non-small-cell-lung-cancer-50752 https://curecurrent.com/trials/safety-and-efficacy-study-of-epitope-peptide-to-treat-hla-a-24-disease-controlled-advanced-non-small-cell-lung-cancer-50753 https://curecurrent.com/trials/intrathecal-pemetrexed-for-recurrent-leptomeningeal-metastases-from-non-small-cell-lung-cancer-50754 https://curecurrent.com/trials/safety-study-of-peptide-cancer-vaccine-to-treat-hla-a-02-positive-advanced-non-small-cell-lung-cancer-50755 https://curecurrent.com/trials/safety-and-efficacy-study-of-epitope-peptide-to-treat-hla-a-02-disease-controlled-advanced-non-small-cell-lung-cancer-50756 https://curecurrent.com/trials/sintilimab-combined-with-metformin-in-first-line-chemotherapy-refractory-advanced-nsclc-patients-50757 https://curecurrent.com/trials/safety-study-of-peptide-cancer-vaccine-to-treat-hla-a-24-positive-advanced-non-small-cell-lung-cancer-50758 https://curecurrent.com/trials/safety-study-of-peptide-cancer-vaccine-to-treat-hla-a-24-positive-advanced-small-cell-lung-cancer-50759 https://curecurrent.com/trials/a-dose-escalation-expansion-study-of-ldk378-in-patients-with-tumors-characterized-by-genetic-abnormalities-in-anaplastic-50760 https://curecurrent.com/trials/an-expanded-access-programme-with-iressa-for-patients-with-non-small-cell-lung-cancer-and-cancer-of-the-head-and-neck-50761 https://curecurrent.com/trials/investigation-of-the-effect-of-nintedanib-on-the-pharmacokinetics-of-a-combination-of-ethinylestradiol-and-levonorgestre-50762 https://curecurrent.com/trials/lung-cancer-registry-for-lung-cancer-patients-50763 https://curecurrent.com/trials/a-phase-i-ii-open-label-non-randomized-dose-escalation-study-of-immunoconjugate-l-dos47-50764 https://curecurrent.com/trials/tissue-microarrays-tmas-construction-in-lung-cancer-samples-50765 https://curecurrent.com/trials/radiomics-multifactorial-biomarker-for-pulmonary-nodules-50766 https://curecurrent.com/trials/whole-brain-radiation-with-or-without-erlotinib-for-brain-metastases-from-non-small-cell-lung-cancer-50767 https://curecurrent.com/trials/tipifarnib-plus-radiation-therapy-after-combination-chemotherapy-in-treating-patients-with-stage-iii-non-small-cell-lung-50768 https://curecurrent.com/trials/pilot-study-to-evaluate-optical-frequency-domain-imaging-for-diagnosis-of-central-airway-disease-50769 https://curecurrent.com/trials/neoantigen-primed-dc-vaccines-therapy-for-refractory-lung-cancer-50770 https://curecurrent.com/trials/image-guided-functional-lung-avoidance-thoracic-radiotherapy-for-lung-cancer-a-single-blind-randomized-trial-50771 https://curecurrent.com/trials/outcome-of-cisplatin-and-vinblastine-versus-paclitaxel-and-carboplatin-as-sequential-chemotherapy-followed-by-radiothera-50772 https://curecurrent.com/trials/20k-distributed-learning-challenge-50773 https://curecurrent.com/trials/itacitinib-in-combination-with-erlotinib-in-non-small-cell-lung-cancer-patients-with-epidermal-growth-factor-receptor-eg-50774 https://curecurrent.com/trials/study-of-stepped-palliative-care-in-patients-with-advanced-lung-cancer-df-hcc-social-behavioral-reserach-protocol-50775 https://curecurrent.com/trials/intrapleural-docetaxel-administration-using-medical-pleuroscopy-in-malignant-effusion-with-lung-cancer-50776 https://curecurrent.com/trials/radiofrequency-ablation-in-resectable-colorectal-lung-metastasis-50777 https://curecurrent.com/trials/trial-of-erlotinib-and-bkm120-in-patients-with-advanced-non-small-cell-lung-cancer-previously-sensitive-to-erlotinib-50778 https://curecurrent.com/trials/cancer-venous-thromboembolism-vte-50779 https://curecurrent.com/trials/sorafenib-in-treating-non-smokers-or-former-light-smokers-with-relapsed-or-refractory-stage-iiib-or-stage-iv-non-small-c-50780 https://curecurrent.com/trials/phase-1-study-of-intradermal-lv305-in-patients-with-locally-advanced-relapsed-or-metastatic-cancer-expressing-ny-eso-1-50781 https://curecurrent.com/trials/a-study-of-paclitaxel-and-carboplatin-in-combination-with-bexarotene-oral-capsules-in-patients-with-advanced-lung-cancer-50782 https://curecurrent.com/trials/dexamethasone-flurbiprofen-axetil-and-long-term-survival-after-lung-cancer-surgery-50783 https://curecurrent.com/trials/a-feasibility-study-of-unsupervised-pre-operative-exercise-program-for-patients-scheduled-for-lung-cancer-surgery-50784 https://curecurrent.com/trials/dasatinib-in-treating-patients-with-stage-iiib-stage-iv-or-recurrent-non-small-cell-lung-cancer-50785 https://curecurrent.com/trials/erlotinib-with-or-without-fulvestrant-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-50786 https://curecurrent.com/trials/nivolumab-and-plinabulin-in-treating-patients-with-stage-iiib-iv-recurrent-or-metastatic-non-small-cell-lung-cancer-50787 https://curecurrent.com/trials/evaluation-of-the-impact-of-nurse-led-telephone-on-treatment-compliance-50788 https://curecurrent.com/trials/abivertinib-maleate-versus-geifitinib-in-patients-with-advanced-non-small-cell-lung-cancer-with-sensitive-egfr-mutation-50789 https://curecurrent.com/trials/the-effects-of-two-different-ventilation-strategies-on-lung-ventilation-an-ultrasonographic-evaluation-50790 https://curecurrent.com/trials/lung-cancer-screening-by-low-dose-ct-scan-in-a-french-department-dep-kp80-50791 https://curecurrent.com/trials/the-symptom-experience-study-in-persons-with-non-small-cell-lung-cancer-50792 https://curecurrent.com/trials/probiotics-combined-with-chemotherapy-for-patients-with-advanced-nsclc-50793 https://curecurrent.com/trials/functional-image-and-molecular-markers-to-predict-treatment-outcomes-in-lung-cancer-50794 https://curecurrent.com/trials/liquid-biopsy-as-a-tool-to-evaluate-resistance-to-first-and-third-azd9291-egfr-tkis-in-egfr-mutant-nsclc-50795 https://curecurrent.com/trials/chest-wall-motion-analysis-in-disease-50796 https://curecurrent.com/trials/frequency-of-egfr-and-kras-mutations-and-clinical-prognostic-correlation-in-brazilian-lung-cancer-patients-50797 https://curecurrent.com/trials/ldk378-in-adult-chinese-patients-with-alk-rearranged-alk-positive-advanced-non-small-cell-lung-cancer-nsclc-previously-t-50798 https://curecurrent.com/trials/mitochondria-targeted-system-therapy-combined-with-radiofrequency-ablation-for-early-stage-non-small-cell-lung-cancer-50799 https://curecurrent.com/trials/clinical-trial-of-the-efficacy-and-safety-of-ac0010-in-the-treatment-of-egfr-t790m-patients-with-advanded-nsclc-50800 https://curecurrent.com/trials/high-dose-icotinib-with-sequential-srs-for-nsclc-patients-harboring-egfr-mutation-with-brain-metastases-50801 https://curecurrent.com/trials/side-effects-of-anti-pd-l-1-and-anti-ctla-a4-in-the-non-small-cells-lung-cancer-50802 https://curecurrent.com/trials/clinical-and-molecular-staging-of-lung-cancer-stages-i-and-iip-50803 https://curecurrent.com/trials/a-study-of-atezolizumab-compared-with-gemcitabine-plus-cisplatin-or-carboplatin-for-pd-l1-selected-participants-with-sta-50804 https://curecurrent.com/trials/nitroglycerin-in-non-small-cell-lung-cancer-50805 https://curecurrent.com/trials/lux-lung-8-a-phase-iii-trial-of-afatinib-bibw-2992-versus-erlotinib-for-the-treatment-of-squamous-cell-lung-cancer-after-50806 https://curecurrent.com/trials/epidermal-growth-factor-receptor-mutations-in-the-blood-of-patients-with-advanced-non-small-cell-lung-cancer-50807 https://curecurrent.com/trials/exercise-capacity-and-physical-activity-levels-in-newly-diagnosed-hematologic-malignant-patients-50808 https://curecurrent.com/trials/chloroquine-as-an-anti-autophagy-drug-in-stage-iv-small-cell-lung-cancer-sclc-patients-50809 https://curecurrent.com/trials/the-tracking-molecular-evolution-for-nsclc-t-menc-study-50810 https://curecurrent.com/trials/donor-lymphocyte-infusion-after-stem-cell-transplant-in-treating-patients-with-haematological-cancers-50811 https://curecurrent.com/trials/fitness-activity-and-lung-cancer-study-50812 https://curecurrent.com/trials/a-phase-iii-clinical-trial-of-fruquintinib-in-patients-with-advanced-non-small-cell-lung-cancer-50813 https://curecurrent.com/trials/maximal-exercise-capacity-and-extra-pulmonary-characteristics-in-patients-with-lung-cancer-with-complete-remission-50814 https://curecurrent.com/trials/study-of-weekly-paclitaxel-carboplatin-and-irinotecan-to-treat-lung-cancer-50815 https://curecurrent.com/trials/a-trial-comparing-approaches-to-shared-decision-making-skills-training-for-clinicians-50816 https://curecurrent.com/trials/a-pilot-study-of-mpdl3280a-and-higrt-in-metastatic-nsclc-50817 https://curecurrent.com/trials/a-phase-1b-study-of-pegylated-recombinant-human-hyaluronidase-pegph20-combined-with-docetaxel-in-subjects-with-recurrent-50818 https://curecurrent.com/trials/pet-quantitative-assessments-of-solid-tumor-response-to-immune-checkpoint-blockade-therapy-50819 https://curecurrent.com/trials/a-comparative-study-of-pf-06439535-plus-paclitaxel-carboplatin-and-bevacizumab-plus-paclitaxel-carboplatin-patients-with-50820 https://curecurrent.com/trials/folic-acid-tubulysin-conjugate-ec1456-in-patients-with-advanced-solid-tumors-50821 https://curecurrent.com/trials/concurrent-proton-and-chemotherapy-in-locally-advanced-stage-iiia-b-non-small-cell-lung-cancer-nsclc-50822 https://curecurrent.com/trials/a-study-of-ly2584702-with-erlotinib-or-everolimus-in-participants-with-solid-tumors-50823 https://curecurrent.com/trials/azacitidine-and-entinostat-in-treating-patients-with-stage-i-non-small-cell-lung-cancer-that-has-been-removed-by-surgery-50824 https://curecurrent.com/trials/retrospective-analysis-of-the-expression-of-the-neurotensin-receptor-by-metastatic-lung-adenocarcinomas-50825 https://curecurrent.com/trials/efficacy-and-safety-of-momelotinib-combined-with-trametinib-in-adults-with-metastatic-kras-mutated-non-small-cell-lung-c-50826 https://curecurrent.com/trials/photodynamic-therapy-for-the-prevention-of-lung-cancer-50827 https://curecurrent.com/trials/erlotinib-and-momelotinib-for-the-treatment-of-epidermal-growth-factor-receptor-egfr-mutated-egfr-tyrosine-kinase-inhibi-50828 https://curecurrent.com/trials/phase-ii-study-of-itraconazole-and-pemetrexed-in-patients-with-previously-treated-non-squamous-nsclc-50829 https://curecurrent.com/trials/study-of-coti-2-as-monotherapy-or-combination-therapy-for-the-treatment-of-malignancies-50830 https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-sh-1028-in-locally-advanced-or-metastatic-nsclc-50831 https://curecurrent.com/trials/therapeutic-strategies-in-patients-with-non-squamous-non-small-cell-lung-cancer-with-brain-metastases-50832 https://curecurrent.com/trials/biomarker-discovery-and-validation-in-lung-cancer-50833 https://curecurrent.com/trials/phase-i-ii-study-to-evaluate-the-efficacy-and-safety-of-a-combination-chemotherapy-50834 https://curecurrent.com/trials/preliminary-evaluation-of-safety-and-efficacy-by-14c-ac0010-trail-and-subsequent-ac0010-treatment-50835 https://curecurrent.com/trials/prospective-randomized-trial-comparing-the-effectiveness-of-continuous-paravertebral-infusion-of-local-anesthetics-versu-50836 https://curecurrent.com/trials/monitoring-the-changes-of-tumor-related-biomarkers-before-and-after-pulmonary-nodule-biopsy-50837 https://curecurrent.com/trials/nutritional-route-in-esophageal-resection-trial-ii-50838 https://curecurrent.com/trials/anlotinib-hydrochloride-combined-with-egfr-tkis-in-advanced-non-small-cell-lung-cancer-50839 https://curecurrent.com/trials/a-prospective-multi-center-evaluation-of-a-powered-vascular-stapler-in-video-assisted-thoracoscopic-lobectomies-50840 https://curecurrent.com/trials/efficacy-of-epidermal-growth-factor-receptor-tyrosine-kinase-inhibitor-combined-with-early-stereotactic-body-radiation-t-50841 https://curecurrent.com/trials/temozolomide-combine-with-intensity-modulated-radiation-therapy-with-simultaneous-integrated-boost-for-non-small-cell-lu-50842 https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-sh-1028-in-patients-with-advanced-nsclc-50843 https://curecurrent.com/trials/bioinformation-therapy-for-lung-cancer-50844 https://curecurrent.com/trials/evaluation-of-tolerability-and-safety-of-allergovac-poliplus-in-polysensitized-patients-with-rhinitis-or-allergic-rhinoc-50845 https://curecurrent.com/trials/temsirolimus-and-bevacizumab-in-treating-patients-with-advanced-endometrial-ovarian-liver-carcinoid-or-islet-cell-cancer-50846 https://curecurrent.com/trials/the-predictive-role-of-programmed-death-ligand-1-pd-l1-and-neutrophil-to-lymphocyte-ratio-nlr-in-non-small-cell-lung-can-50847 https://curecurrent.com/trials/study-of-proteins-in-tumor-samples-from-patients-with-non-small-cell-lung-cancer-50848 https://curecurrent.com/trials/biomarkers-of-angiogenesis-and-disease-in-patients-with-unresectable-malignant-mesothelioma-treated-on-clinical-trial-ca-50849 https://curecurrent.com/trials/prospective-study-to-evaluate-mapleson-circuit-with-monitored-anesthesia-care-during-endobronchial-ultrasound-ebus-bronc-50850 https://curecurrent.com/trials/non-invasive-ctdna-methylation-detection-for-lung-nodule-patients-50851 https://curecurrent.com/trials/study-to-evaluate-safety-and-efficacy-of-oral-mp1032-in-psoriasis-patients-50852 https://curecurrent.com/trials/the-efficacy-and-drug-resistance-molecular-biology-of-apatinib-combined-with-egfr-tk1-treated-for-advanced-slow-progress-50853 https://curecurrent.com/trials/cancer-panel-from-blood-of-lung-cancer-patients-50854 https://curecurrent.com/trials/the-real-word-study-of-albumin-binding-taxol-for-lung-cancer-treatment-50855 https://curecurrent.com/trials/grn1005-in-non-small-cell-lung-cancer-nsclc-patients-with-brain-metastases-grabm-l-50856 https://curecurrent.com/trials/molecular-profiling-in-small-cell-lung-cancer-50857 https://curecurrent.com/trials/an-explorative-study-of-afatinib-in-the-treatment-of-advanced-cancer-carrying-an-egfr-a-her2-or-a-her3-mutation-50858 https://curecurrent.com/trials/a-study-of-famitinib-plus-docetaxel-in-patients-with-advanced-non-squamous-and-non-small-cell-lung-cancer-nsclc-50859 https://curecurrent.com/trials/a-fish-oil-supplement-to-maintain-body-weight-in-patients-with-disease-related-weight-loss-50860 https://curecurrent.com/trials/shr1020-plus-docetaxel-as-compared-to-placebo-plus-docetaxel-in-2nd-line-non-squamous-non-small-cell-lung-cancer-50861 https://curecurrent.com/trials/a-comprehensive-smoking-cessation-intervention-duration-radiation-for-upper-aerodigestive-cancers-50862 https://curecurrent.com/trials/ny-eso-1-tcr-taest16001-for-patients-with-advanced-nsclc-50863 https://curecurrent.com/trials/docetaxel-and-cisplatin-in-treating-patients-with-stage-i-stage-ii-or-stage-iii-non-small-cell-lung-cancer-that-has-been-50864 https://curecurrent.com/trials/retrospective-epidemiological-study-of-lung-cancer-with-low-dose-multislice-computed-tomography-50865 https://curecurrent.com/trials/efficacy-and-safety-of-sct200-in-patients-with-advanced-squamous-non-small-cell-lung-cancer-50866 https://curecurrent.com/trials/clinical-trial-to-evaluate-the-safety-and-effects-of-ethnicity-and-food-on-pharmacokinetics-of-yh25448-50867 https://curecurrent.com/trials/study-of-ngr-htnf-as-single-agent-in-patients-affected-by-advanced-or-metastatic-malignant-pleural-mesothelioma-50868 https://curecurrent.com/trials/stereotactic-body-radiation-therapy-in-treating-patients-with-inoperable-stage-i-or-stage-ii-non-small-cell-lung-cancer-50869 https://curecurrent.com/trials/trial-of-ruxolitinib-and-erlotinib-in-patients-with-egfr-mutant-lung-adenocarcinoma-with-acquired-resistance-to-erlotini-50870 https://curecurrent.com/trials/shr-1210-combined-with-epirubicin-in-the-treatment-of-extensive-disease-small-cell-lung-cancer-50871 https://curecurrent.com/trials/zoledronic-acid-combined-radiotherapy-for-bone-metastasis-of-non-small-cell-lung-cancer-50872 https://curecurrent.com/trials/preoperative-and-postoperative-ctdna-comparison-in-early-stage-lung-cancer-50873 https://curecurrent.com/trials/phase-ii-study-of-ngr-htnf-versus-placebo-as-maintenance-treatment-in-patients-with-advanced-mpm-50874 https://curecurrent.com/trials/efficacy-and-safety-study-of-afatinib-to-treat-lung-cancer-patients-50875 https://curecurrent.com/trials/human-mesenchymal-stem-cells-for-moderate-and-severe-bronchopulmonary-dysplasia-50876 https://curecurrent.com/trials/effect-of-optimal-positive-end-expiratory-pressure-on-oxygenation-and-intrapulmonary-shunt-during-one-lung-ventilation-50877 https://curecurrent.com/trials/isotoxic-accelerated-radiotherapy-in-locally-advanced-non-small-cell-lung-cancer-the-phase-i-ii-i-start-trial-50878 https://curecurrent.com/trials/proton-radiotherapy-for-patients-with-non-small-cell-lung-cancer-nsclc-50879 https://curecurrent.com/trials/electromagnetic-navigation-versus-ct-guided-ttna-in-the-diagnosis-of-early-peripheral-lung-cancer-50880 https://curecurrent.com/trials/18f-hx4-pet-ct-imaging-for-detection-of-hypoxia-50881 https://curecurrent.com/trials/betadine-pleurodesis-via-tunneled-pleural-catheters-50882 https://curecurrent.com/trials/a-study-of-ldk378-in-patients-with-non-small-cell-lung-cancer-harboring-ros1-rearrangement-50883 https://curecurrent.com/trials/sorafenib-and-high-dose-carboplatin-paclitaxel-and-external-beam-radiation-therapy-in-treating-patients-with-stage-iii-n-50884 https://curecurrent.com/trials/vitamin-c-and-tyrosine-kinase-inhibitor-in-lung-cancer-patients-with-epidermal-growth-factor-receptor-mutations-50885 https://curecurrent.com/trials/docetaxel-combined-with-carboplatin-plus-anlotinib-as-first-line-treatment-in-nsclc-50886 https://curecurrent.com/trials/18f-fluorodeoxyglucose-18f-fdg-positron-emission-tomography-in-oncology-50887 https://curecurrent.com/trials/a-study-of-paclitaxel-carboplatin-with-or-without-olaratumab-imc-3g3-in-previously-untreated-locally-advanced-or-metasta-50888 https://curecurrent.com/trials/clinicopathological-features-of-nsclc-patients-associated-with-the-chromosome-2p-eml4-alk-50889 https://curecurrent.com/trials/study-of-dacomitinib-pf-00299804-in-advanced-nsclc-patients-post-chemo-or-select-first-line-to-evaluate-prophylactic-int-50890 https://curecurrent.com/trials/early-diagnosis-of-small-pulmonary-nodules-by-multi-omics-sequencing-50891 https://curecurrent.com/trials/spanish-lung-liquid-vs-invasive-biopsy-program-sllip-50892 https://curecurrent.com/trials/dacomitinib-pf-00299804-as-a-single-oral-agent-in-selected-patients-with-adenocarcinoma-of-the-lung-50893 https://curecurrent.com/trials/study-of-tarceva-and-targretin-oral-capsules-in-patients-with-advanced-lung-cancer-50894 https://curecurrent.com/trials/a-study-of-atezolizumab-in-participants-with-programmed-death-ligand-1-pd-l1-positive-locally-advanced-or-metastatic-non-50895 https://curecurrent.com/trials/study-of-tarceva-and-targretin-in-stage-i-ii-lung-cancer-50896 https://curecurrent.com/trials/rshf-in-colorectal-cancer-50897 https://curecurrent.com/trials/ngs-genome-analysis-in-personalisation-of-lung-cancer-treatment-50898 https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-sct510-in-the-treatment-of-non-small-cell-lung-cancer-50899 https://curecurrent.com/trials/pharmacogenetics-in-non-small-cell-lung-cancer-50900 https://curecurrent.com/trials/evaluating-an-anchored-transponder-in-lung-cancer-patients-receiving-radiation-therapy-50901 https://curecurrent.com/trials/pilot-study-of-preoperative-tarceva-erlotinib-for-stages-i-ii-non-small-cell-lung-cancer-50902 https://curecurrent.com/trials/a-study-of-ly2940680-in-small-cell-lung-cancer-50903 https://curecurrent.com/trials/the-correlation-of-pd-l1-expression-in-non-small-lung-cancer-tissue-and-peripheral-blood-t-cell-and-serum-50904 https://curecurrent.com/trials/a-randomized-study-to-compare-the-efficacy-and-safety-of-belotecan-and-topotecan-as-monotherapy-for-sensitive-relapsed-s-50905 https://curecurrent.com/trials/phase-2-study-of-alisertib-mln8237-in-combination-with-paclitaxel-versus-placebo-in-combination-with-paclitaxel-as-secon-50906 https://curecurrent.com/trials/aggressive-thoracic-radiotherapy-for-stage-non-small-cell-lung-cancer-50907 https://curecurrent.com/trials/study-evaluating-the-safety-of-rovalpituzumab-tesirine-for-third-line-and-later-treatment-of-subjects-with-relapsed-or-r-50908 https://curecurrent.com/trials/a-phase-3-multi-site-randomized-double-blind-placebo-controlled-study-of-the-efficacy-and-safety-comparing-cp-690-550-an-50909 https://curecurrent.com/trials/a-study-to-evaluate-the-effects-and-safety-of-treatment-treatment-withdrawal-followed-by-re-treatment-with-cp-690-550-in-50910 https://curecurrent.com/trials/high-flow-nasal-cannula-oxygen-versus-conventional-oxygen-therapy-after-pulmonary-lobectomy-50911 https://curecurrent.com/trials/concurrent-egfr-tkis-and-thoracic-radiation-therapy-in-active-egfr-mutation-for-1st-line-treatment-of-stage-iv-nsclc-50912 https://curecurrent.com/trials/efficacy-and-safety-of-anlotinib-as-maintenance-treatment-after-first-line-chemotherapy-in-sclc-50913 https://curecurrent.com/trials/mcmaster-catheterization-for-thoracoscopic-surgery-study-50914 https://curecurrent.com/trials/a-novel-erythropoiesis-stimulating-protein-nesp-darbopoetin-alfa-for-the-treatment-of-anemia-in-lung-cancer-patients-rec-50915 https://curecurrent.com/trials/does-intense-regimented-surveillance-improve-the-rates-of-therapeutic-re-intervention-after-lung-cancer-surgery-50916 https://curecurrent.com/trials/videothoracoscopic-vats-vs-robotic-approach-for-lobectomy-or-anatomical-segmentectomy-50917 https://curecurrent.com/trials/study-of-anlotinib-as-the-maintenance-therapy-for-extensive-stage-small-cell-lung-cancer-50918 https://curecurrent.com/trials/application-of-3d-printing-technique-in-small-pulmonary-nodule-localization-50919 https://curecurrent.com/trials/study-of-anlotinib-combined-with-pemetrexed-in-patients-with-advanced-nonsquamous-nsclc-50920 https://curecurrent.com/trials/study-of-metformin-plus-paclitaxel-carboplatin-bevacizumab-in-patients-with-adenocarcinoma-50921 https://curecurrent.com/trials/autologous-tcm-cells-immunotherapy-in-patients-with-non-small-cell-lung-cancer-nsclc-50922 https://curecurrent.com/trials/peg-rhg-csf-in-elderly-patients-with-small-cell-lung-cancer-receiving-chemotherapy-50923 https://curecurrent.com/trials/afatinib-as-second-line-therapy-for-lung-cancer-with-epidermal-growth-factor-receptor-egfr-mutation-50924 https://curecurrent.com/trials/careseng-1370-for-chemotherapy-induced-myelosuppression-50925 https://curecurrent.com/trials/a-study-of-prexasertib-ly2606368-in-combination-with-ralimetinib-in-participants-with-advanced-or-metastatic-cancer-50926 https://curecurrent.com/trials/a-study-of-induction-and-maintenance-treatment-of-advanced-non-squamous-non-small-cell-lung-cancer-50927 https://curecurrent.com/trials/bibw-2992-afatinib-vs-gemcitabine-cisplatin-in-1st-line-non-small-cell-lung-cancer-nsclc-50928 https://curecurrent.com/trials/spect-ct-in-measuring-lung-function-in-patients-with-cancer-undergoing-radiation-therapy-50929 https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-50930 https://curecurrent.com/trials/nsclc-heterogeneity-in-early-stage-patients-and-prediction-of-relapse-using-a-personalized-liquid-biopsy-50931 https://curecurrent.com/trials/erlotinib-in-patients-with-resected-early-stage-nsclc-with-confirmed-mutations-in-the-egfr-50932 https://curecurrent.com/trials/sgi-110-plus-durvalumab-tremelimumab-in-sclc-50933 https://curecurrent.com/trials/phase-ii-safety-and-tolerability-trial-with-nab-paclitaxel-plus-carboplatin-followed-by-nab-paclitaxel-for-first-line-tr-50934 https://curecurrent.com/trials/anlotinib-plus-sintilimab-for-nsclc-patients-with-first-generation-egfr-tkis-drug-resistance-along-with-t790m-negative-50935 https://curecurrent.com/trials/erlotinib-paclitaxel-and-carboplatin-in-treating-patients-with-stage-iii-stage-iv-or-recurrent-non-small-cell-lung-cance-50936 https://curecurrent.com/trials/docetaxel-and-erlotinib-in-treating-patients-with-advanced-non-small-cell-lung-cancer-or-other-solid-tumors-50937 https://curecurrent.com/trials/lume-lung-1-bibf-1120-plus-docetaxel-as-compared-to-placebo-plus-docetaxel-in-2nd-line-non-small-cell-lung-cancer-50938 https://curecurrent.com/trials/bavituximab-plus-carbo-and-pemetrexed-in-chemo-naive-stage-iv-non-squamous-non-small-cell-lung-cancer-nsclc-subjects-50939 https://curecurrent.com/trials/localization-for-deep-lung-nodules-microcoil-versus-contrast-injection-50940 https://curecurrent.com/trials/a-phase-ii-study-of-neo-adjuvant-gemcitabine-cisplatin-and-bevacizumab-in-stage-iiia-n2-non-squamous-cell-non-small-cell-50941 https://curecurrent.com/trials/safety-and-efficacy-of-vitamin-c-infusion-in-combination-with-local-meht-to-treat-non-small-cell-lung-cancer-50942 https://curecurrent.com/trials/a-study-of-anlotinib-in-combination-with-docetaxel-versus-docetaxel-alone-in-participants-with-advanced-nsclc-50943 https://curecurrent.com/trials/icotinib-combined-with-radiation-therapy-for-nsclc-patients-with-brain-metastases-and-egfr-mutation-50944 https://curecurrent.com/trials/azd-2811-monotherapy-in-relapsed-small-cell-lung-cancer-patients-sukses-n3-50945 https://curecurrent.com/trials/anlotinib-combined-with-docetaxel-for-advanced-non-squamous-non-small-cell-lung-cancer-50946 https://curecurrent.com/trials/phase-ib-iia-studies-of-chlorogenic-acid-for-injection-for-safety-and-efficacy-of-advanced-lung-cancer-50947 https://curecurrent.com/trials/perfusion-ct-imaging-in-lung-cancer-with-sbrt-50948 https://curecurrent.com/trials/changes-in-circulating-tumor-specific-dna-in-patients-with-non-metastatic-non-small-cell-lung-cancer-50949 https://curecurrent.com/trials/nlcr-in-prediction-of-the-grade-of-lung-tumor-50950 https://curecurrent.com/trials/icotinib-as-neoadjuvant-therapy-in-egfr-mutant-stage-a-n2-non-small-cell-lung-cancer-50951 https://curecurrent.com/trials/proton-beam-re-irradiation-in-thoracic-cancers-50952 https://curecurrent.com/trials/a-study-of-the-safety-tolerability-and-effects-of-cobimetinib-and-gdc-0994-in-patients-with-locally-advanced-or-metastat-50953 https://curecurrent.com/trials/effect-of-osimertinib-in-ethnic-chinese-with-egfr-and-t790m-mutated-nsclc-50954 https://curecurrent.com/trials/feasibility-of-a-creative-writing-intervention-in-an-advanced-cancer-population-a-single-arm-consecutive-cohort-study-50955 https://curecurrent.com/trials/using-a-patient-centered-mhealth-intervention-to-improve-adherence-to-oral-anticancer-medications-50956 https://curecurrent.com/trials/effect-of-yong-chong-cao-capsule-on-outcomes-in-patients-with-mild-to-severe-copd-50957 https://curecurrent.com/trials/epidermal-growth-factor-receptor-egfr-t790m-mutation-testing-practices-in-hong-kong-50958 https://curecurrent.com/trials/lung-protective-ventilation-during-robotic-assisted-prostatectomy-50959 https://curecurrent.com/trials/safety-study-of-cb-5945-for-the-treatment-of-opioid-induced-constipation-50960 https://curecurrent.com/trials/the-efficacy-and-safety-study-of-cb-5945-for-the-treatment-of-opioid-induced-constipation-50961 https://curecurrent.com/trials/efficacy-and-safety-study-of-cb-5945-for-the-treatment-of-opioid-induced-constipation-50962 https://curecurrent.com/trials/randomized-study-of-maintenance-therapy-with-mgn1703-in-patients-with-sclc-50963 https://curecurrent.com/trials/sorafenib-and-thoracic-radiation-for-patients-with-non-small-cell-lung-cancer-50964 https://curecurrent.com/trials/efficacy-and-safety-study-of-cb-5945-for-the-treatment-of-opioid-induced-constipation-50965 https://curecurrent.com/trials/expanded-access-study-of-afatinib-in-treatment-naive-or-chemotherapy-pre-treated-patients-with-non-small-cell-lung-cance-50966 https://curecurrent.com/trials/nivolumab-in-the-real-world-analysis-of-the-expanded-use-in-spanish-patient-50967 https://curecurrent.com/trials/radiation-therapy-xrt-and-zd6474-in-non-small-cell-lung-cancer-nsclc-50968 https://curecurrent.com/trials/circulating-tumor-dna-longitudinal-monitoring-in-stage-iii-iv-lung-cancer-patients-50969 https://curecurrent.com/trials/low-dose-daily-erlotinib-in-combination-with-high-dose-twice-weekly-erlotinib-in-patients-with-egfr-mutant-lung-cancer-50970 https://curecurrent.com/trials/temozolomide-in-patients-affected-by-relapsed-sensitive-or-refractory-small-cell-lung-cancer-with-mgmt-methylation-50971 https://curecurrent.com/trials/disease-characteristics-treatment-patterns-and-clinical-outcomes-in-patients-with-newly-diagnosed-unresectable-stage-iii-50972 https://curecurrent.com/trials/study-of-patient-preference-for-oral-or-intravenous-vinorelbine-in-the-treatment-of-advanced-nsclc-50973 https://curecurrent.com/trials/prevention-of-post-operative-pneumonia-popp-50974 https://curecurrent.com/trials/ofatumumab-vs-physician-s-choice-in-subjects-with-bulky-fludarabine-refractory-chronic-lymphocytic-leukemia-50975 https://curecurrent.com/trials/anlotinib-combined-with-docetaxel-for-advanced-non-small-cell-lung-cancer-alter-l034-50976 https://curecurrent.com/trials/avastin-and-tarceva-for-locally-advanced-or-metastatic-non-squamous-non-small-cell-lung-cancer-50977 https://curecurrent.com/trials/anlotinib-in-treatment-of-recurrent-small-cell-lung-cancer-50978 https://curecurrent.com/trials/natrecor-in-pulmonary-hypertension-50979 https://curecurrent.com/trials/narrow-band-imaging-nbi-a-novel-imaging-modality-in-minimally-invasive-50980 https://curecurrent.com/trials/bevacizumab-in-the-treatment-of-malignant-pleural-effusions-of-non-squamous-non-small-cell-lung-cancer-50981 https://curecurrent.com/trials/thoracoscopic-lung-cancer-staging-with-the-use-of-intraoperative-ultrasound-50982 https://curecurrent.com/trials/anlotinib-hydrochloride-as-second-line-therapy-in-elderly-patients-with-egfr-wild-type-lung-adenocarcinoma-50983 https://curecurrent.com/trials/a-study-of-alectinib-ro5424802-in-participants-with-non-small-cell-lung-cancer-who-have-anaplastic-lymphoma-kinase-alk-m-50984 https://curecurrent.com/trials/simultaneous-coronary-artery-evaluation-and-lung-cancer-ct-screening-50985 https://curecurrent.com/trials/engagement-of-patients-with-advanced-cancer-50986 https://curecurrent.com/trials/isotoxic-intensity-modulated-radiotherapy-imrt-in-stage-iii-non-small-cell-lung-cancer-nsclc-a-feasibility-study-50987 https://curecurrent.com/trials/bortezomib-and-pemetrexed-disodium-in-treating-patients-with-advanced-non-small-cell-lung-cancer-or-other-solid-tumors-50988 https://curecurrent.com/trials/a-study-of-erlotinib-in-participants-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-with-epidermal-growt-50989 https://curecurrent.com/trials/sunitinib-in-never-smokers-with-lung-adenocarcinoma-50990 https://curecurrent.com/trials/detection-of-heterogeneity-in-central-lung-cancer-ebus-tbna-and-ctdna-analysis-vs-endobronchial-forceps-biopsy-50991 https://curecurrent.com/trials/phase-ii-study-of-sch66336-a-farnesyltransferase-inhibitor-in-chronic-myelogenous-leukemia-cml-50992 https://curecurrent.com/trials/anticoagulation-length-in-cancer-associated-thrombosis-50993 https://curecurrent.com/trials/paclitaxel-detection-in-nsclc-treated-with-tc-regimen-50994 https://curecurrent.com/trials/progression-of-untreated-pulmonary-ground-glass-opacity-50995 https://curecurrent.com/trials/a-study-of-patient-reported-outcomes-in-patients-with-lung-or-esophageal-cancer-50996 https://curecurrent.com/trials/cisplatin-and-gemcitabine-plus-trastuzumab-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-50997 https://curecurrent.com/trials/parp-inhibitor-in-advanced-non-small-cell-lung-cancer-pin-50998 https://curecurrent.com/trials/4-dimensional-ct-derived-ventilation-versus-spect-aerosol-ventilation-in-patients-with-thoracic-malignancies-50999 https://curecurrent.com/trials/efficacy-and-safety-of-apatinib-as-third-line-therapy-for-primary-pulmonary-lymphoepithelioid-carcinoma-51000 https://curecurrent.com/trials/a-study-comparing-oxycodone-to-oxycodone-naloxone-in-moderate-to-severe-chronic-cancer-pain-51001 https://curecurrent.com/trials/carboplatin-and-etoposide-in-combination-with-vorinostat-for-patients-with-extensive-stage-small-cell-lung-cancer-51002 https://curecurrent.com/trials/4-18f-fluoroglutamine-pet-ct-in-imaging-patients-with-newly-diagnosed-lung-cancer-or-indeterminate-pulmonary-nodules-51003 https://curecurrent.com/trials/a-phase-i-study-of-belinostat-in-combination-with-cisplatin-and-etoposide-in-adults-with-small-cell-lung-carcinoma-and-o-51004 https://curecurrent.com/trials/a-dose-finding-and-expansion-study-of-ro7051790-administered-orally-in-participants-with-relapsed-extensive-stage-diseas-51005 https://curecurrent.com/trials/modeling-of-the-response-to-hypofractionated-stereotactic-pulmonary-irradiation-51006 https://curecurrent.com/trials/study-of-ly573636-sodium-in-patients-with-metastatic-non-small-cell-lung-cancer-51007 https://curecurrent.com/trials/a-study-to-explore-treatment-regimens-and-clinical-outcomes-of-the-nsclc-patients-with-different-dirver-genes-51008 https://curecurrent.com/trials/a-randomized-phase-ii-study-of-subatm-itraconazole-in-patients-with-untreated-squamous-nsclc-51009 https://curecurrent.com/trials/rh-endostatin-endostar-continuous-intravenous-infusion-51010 https://curecurrent.com/trials/sunitinib-non-small-cell-lung-cancer-patients-over-70-51011 https://curecurrent.com/trials/early-cancer-detection-test-lung-cancer-scotland-51012 https://curecurrent.com/trials/whole-body-electromyostimulation-and-nutritional-therapy-for-patients-with-esophageal-and-bronchial-carcinoma-51013 https://curecurrent.com/trials/two-radiation-dose-schedules-of-sbrt-to-lung-metastases-5cm-in-dimension-51014 https://curecurrent.com/trials/the-impact-of-trimodal-prehabilitation-strategy-on-patients-undergoing-thoracoscopic-lobectomy-51015 https://curecurrent.com/trials/therapeutic-yoga-and-resistance-exercise-for-lung-cancer-51016 https://curecurrent.com/trials/a-study-of-val401-in-the-treatment-of-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-51017 https://curecurrent.com/trials/a-study-of-sbrt-in-combination-with-rhgm-csf-for-stage-iv-nsclc-patients-who-failed-in-second-line-chemotherapy-51018 https://curecurrent.com/trials/a-clinical-trial-to-validate-molecular-targets-of-vorinostat-in-patients-with-aerodigestive-tract-cancer-51019 https://curecurrent.com/trials/smoking-cessation-intervention-for-thoracic-patients-51020 https://curecurrent.com/trials/pharmacokinetic-pharmacodynamic-study-of-abt-751-with-carboplatin-in-patients-with-advanced-lung-cancer-51021 https://curecurrent.com/trials/anlotinib-versus-docetaxel-as-the-second-line-treatment-in-egfr-wild-type-patients-with-advanced-nsclc-51022 https://curecurrent.com/trials/prognostic-factors-on-malignant-pleural-effusion-51023 https://curecurrent.com/trials/powered-vascular-stapler-in-video-assisted-thoracoscopic-vat-lobectomies-51024 https://curecurrent.com/trials/safety-and-efficacy-of-buparlisib-bkm120-in-patients-with-untreated-squamous-non-small-cell-lung-cancer-51025 https://curecurrent.com/trials/lung-cancer-and-idiopathic-pulmonary-fibrosis-pathological-and-molecular-characterization-51026 https://curecurrent.com/trials/virtual-intervention-for-lung-cancer-51027 https://curecurrent.com/trials/fdg-pet-ct-scans-in-patients-with-stage-iiib-or-stage-iv-nsclc-undergoing-chemotherapy-51028 https://curecurrent.com/trials/extracolonic-findings-on-computed-tomography-ct-colonography-51029 https://curecurrent.com/trials/minimum-dose-computed-tomography-of-the-thorax-for-follow-up-in-patients-with-resected-lung-carcinoma-51030 https://curecurrent.com/trials/impact-of-perioperative-physical-activity-on-postoperative-pulmonary-complications-and-quality-of-life-among-esophageal-51031 https://curecurrent.com/trials/effect-of-chemotherapy-on-pd-l1-in-nsclc-51032 https://curecurrent.com/trials/clinical-research-of-s-1-versus-pemetrexed-in-the-maintenance-treatment-of-advanced-nsnsclc-51033 https://curecurrent.com/trials/an-investigational-study-of-infliximab-with-prednisone-or-methylprednisolone-versus-prednisone-combination-treatment-in-51034 https://curecurrent.com/trials/assessing-the-combination-of-durvalumab-medi4736-and-trabectedin-in-solid-tumors-51035 https://curecurrent.com/trials/gold-sodium-thiomalate-in-treating-patients-with-advanced-non-small-cell-lung-cancer-51036 https://curecurrent.com/trials/stereotactic-body-radiation-therapy-in-stage-ii-iii-non-small-cell-lung-cancer-51037 https://curecurrent.com/trials/sc-002-in-small-cell-lung-cancer-and-large-cell-neuroendocrine-carcinoma-51038 https://curecurrent.com/trials/3-dimensional-conformal-radiation-therapy-versus-intensity-modulated-radiation-therapy-51039 https://curecurrent.com/trials/extensive-staging-in-lung-cancer-51040 https://curecurrent.com/trials/venous-thromboembolic-complications-in-ovarian-cancer-51041 https://curecurrent.com/trials/pdr001-in-patients-with-non-small-cell-lung-cancer-harboring-kras-nras-mutation-or-no-actionable-genetic-abnormalities-51042 https://curecurrent.com/trials/clinical-evaluation-of-the-treatment-of-intellectual-metastases-by-radiosurgery-gamma-knife-by-means-of-a-support-system-51043 https://curecurrent.com/trials/capmatinib-in-patients-with-non-small-cell-lung-cancer-harboring-cmet-exon14-skipping-mutation-51044 https://curecurrent.com/trials/utb-vbn-ebus-with-or-without-fluoroscopy-for-the-diagnosis-of-ppls-51045 https://curecurrent.com/trials/evaluation-of-efficacy-and-toxicity-of-nivolumab-monotherapy-for-advanced-non-small-cell-lung-cancer-after-first-line-tr-51046 https://curecurrent.com/trials/a-study-of-axitinib-in-advanced-carcinoid-tumors-51047 https://curecurrent.com/trials/phase-1-2-study-of-the-safety-and-efficacy-of-rociletinib-in-combination-with-trametinib-in-patients-with-megfr-positive-51048 https://curecurrent.com/trials/clinical-pharmacokinetics-of-tkis-in-chinese-patients-of-hepatitis-b-hbv-51049 https://curecurrent.com/trials/ngr-htnf-in-combination-with-standard-chemotherapy-to-treat-patients-with-advanced-non-small-cell-lung-cancer-51050 https://curecurrent.com/trials/safety-and-efficacy-of-ttfields-150-khz-concomitant-with-pemetrexed-and-cisplatin-or-carboplatin-in-malignant-pleural-me-51051 https://curecurrent.com/trials/study-of-prevalence-of-ipsilateral-shoulder-pain-in-patients-after-thoracic-surgeries-51052 https://curecurrent.com/trials/ultrathin-bronchoscope-and-radial-endobronchial-ultrasound-r-ebus-with-fluoroscopy-versus-standard-fiberoptic-bronchosco-51053 https://curecurrent.com/trials/rociletinib-co-1686-usa-expanded-access-program-51054 https://curecurrent.com/trials/effect-of-chemotherapy-on-tmb-in-nsclc-51055 https://curecurrent.com/trials/safety-and-efficacy-study-of-abraxane-in-combination-with-carboplatin-to-treat-advanced-nscl-cancer-in-the-elderly-51056 https://curecurrent.com/trials/safety-and-efficacy-clinical-study-of-sns-595-for-second-line-therapy-in-patients-with-advanced-nsclc-51057 https://curecurrent.com/trials/a-study-of-rovalpituzumab-tesirine-to-study-cardiac-ventricular-repolarization-in-subjects-with-small-cell-lung-cancer-51058 https://curecurrent.com/trials/vistusertib-azd2014-monotherapy-in-relapsed-small-cell-lung-cancer-patients-harboring-rictor-amplification-51059 https://curecurrent.com/trials/phase-ii-study-of-azd9291-in-advanced-stage-nsclc-with-egfr-and-t790m-mutations-detected-in-plasma-ct-dna-51060 https://curecurrent.com/trials/phase-ii-single-arm-study-of-azd1775-monotherapy-in-relapsed-small-cell-lung-cancer-patients-with-myc-family-amplificati-51061 https://curecurrent.com/trials/lung-ultrasound-in-detection-of-extravascular-lung-water-in-septic-patients-51062 https://curecurrent.com/trials/extended-low-molecular-weight-heparin-vte-prophylaxis-in-thoracic-surgery-51063 https://curecurrent.com/trials/a-study-on-the-correlation-between-tarceva-erlotinib-induced-rash-and-efficacy-in-egfr-mutated-participants-with-advance-51064 https://curecurrent.com/trials/non-squamous-nsclc-patients-with-anlotinib-combined-with-pemetrexed-and-cisplatin-51065 https://curecurrent.com/trials/concurrent-chemoradiotherapy-combination-with-anlotinib-for-unresectable-stage-iii-nsclc-patients-51066 https://curecurrent.com/trials/lung-cancer-early-diagnosis-with-digital-tomosynthesis-re-evaluation-of-lung-nodule-detection-rate-at-5-years-51067 https://curecurrent.com/trials/life-lung-bronchoscopy-in-patients-at-risk-for-developing-lung-cancer-51068 https://curecurrent.com/trials/a-safety-and-efficacy-trial-of-docetaxel-with-or-without-xh1-in-non-small-cell-lung-cancer-nsclc-patients-51069 https://curecurrent.com/trials/ph-1-trial-of-adi-peg-20-plus-docetaxel-in-solid-tumors-with-emphasis-on-prostate-cancer-and-non-small-cell-lung-cancer-51070 https://curecurrent.com/trials/open-label-extension-study-with-gefitinib-iressa-for-completing-trial-patients-who-may-benefit-from-further-treatment-51071 https://curecurrent.com/trials/a-study-of-tarceva-erlotinib-as-first-line-therapy-in-participants-with-non-small-cell-lung-cancer-harbouring-epidermal-51072 https://curecurrent.com/trials/erlotinib-versus-gemcitabine-cisplatin-as-neo-adjuvant-treatment-in-non-small-cell-lung-cancer-51073 https://curecurrent.com/trials/video-based-intervention-in-reducing-anxiety-in-patients-undergoing-lung-cancer-screening-51074 https://curecurrent.com/trials/itraconazole-in-non-small-cell-lung-cancer-51075 https://curecurrent.com/trials/long-term-observation-pms-for-afatinib-51076 https://curecurrent.com/trials/sublobar-resection-versus-lobectomy-for-ct1n0m0-non-small-cell-lung-cancer-51077 https://curecurrent.com/trials/deferasirox-in-treating-iron-overload-caused-by-blood-transfusions-in-patients-with-hematologic-malignancies-51078 https://curecurrent.com/trials/wt1-immunity-via-dna-fusion-gene-vaccination-in-haematological-malignancies-by-intramuscular-injection-followed-by-intra-51079 https://curecurrent.com/trials/safety-evaluation-of-panitumumab-and-sirolimus-in-advanced-non-small-cell-lung-cancer-51080 https://curecurrent.com/trials/pronostic-and-predictive-value-of-emt-in-localized-lung-cancer-51081 https://curecurrent.com/trials/exercise-in-advanced-stage-lung-cancer-patients-51082 https://curecurrent.com/trials/neoadjuvant-therapy-combined-with-radical-surgery-for-the-treatment-of-small-cell-lung-cancer-sclc-in-ii-and-iiia-stage-51083 https://curecurrent.com/trials/cap7-1-for-the-treatment-of-advanced-stage-therapy-refractory-lung-and-biliary-tract-tumors-51084 https://curecurrent.com/trials/monoclonal-antibody-therapy-in-treating-patients-with-ovarian-epithelial-cancer-melanoma-acute-myeloid-leukemia-myelodys-51085 https://curecurrent.com/trials/endostar-durative-transfusion-combining-with-gemcitabine-cisplatin-to-treat-non-small-cell-lung-cancer-nsclc-51086 https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-gefitinib-in-adjuvant-chemotherapy-for-lung-adenocarcinoma-51087 https://curecurrent.com/trials/bispectral-index-throughout-esophageal-cancer-operation-51088 https://curecurrent.com/trials/anlotinib-plus-docetaxel-for-the-treatment-of-egfr-alk-ros1-mutation-negative-advanced-nonsquamous-nsclc-51089 https://curecurrent.com/trials/a-multicenter-open-label-single-arm-multi-cohort-phase-i-study-of-bcd-100-in-patients-with-advanced-solid-tumors-51090 https://curecurrent.com/trials/neoadjuvant-finasteride-for-patients-with-non-small-cell-lung-cancer-51091 https://curecurrent.com/trials/azd0530-to-treat-recurrent-stage-iiib-iv-nsclc-previously-treated-with-combination-chemotherapy-51092 https://curecurrent.com/trials/mesylate-apatinib-combined-with-irinotecan-in-treatment-of-recurrent-small-cell-lung-cancer-51093 https://curecurrent.com/trials/intermittent-or-continuous-acetylsalicylic-acid-and-gene-expression-in-the-nasal-tissue-of-current-smokers-51094 https://curecurrent.com/trials/feasibility-of-a-web-based-patient-reported-outcome-symptom-monitoring-application-in-danish-lung-cancer-patients-51095 https://curecurrent.com/trials/afatinib-and-selumetinib-in-advanced-kras-mutant-and-pik3ca-wildtype-non-small-cell-lung-cancer-51096 https://curecurrent.com/trials/ultrasound-guided-central-vein-catheterization-and-complications-51097 https://curecurrent.com/trials/photodynamic-therapy-pdt-oncology-registry-51098 https://curecurrent.com/trials/sequence-of-vessel-interruption-and-circulating-tumor-cells-in-surgical-lung-cancer-51099 https://curecurrent.com/trials/efficacy-and-safety-of-ql1101-and-avastin-respectively-combined-with-paclitaxel-and-carboplatin-in-the-first-line-treatm-51100 https://curecurrent.com/trials/epidural-analgesia-and-postoperative-respiratory-functions-epapres-51101 https://curecurrent.com/trials/positive-study-part-iii-heidelberg-51102 https://curecurrent.com/trials/taxotere-enoxaparin-enoxa-study-51103 https://curecurrent.com/trials/study-of-smoking-trajectory-in-newly-diagnosis-lung-cancer-patients-51104 https://curecurrent.com/trials/lc-nmr-study-biomarkers-to-detect-lung-cancer-51105 https://curecurrent.com/trials/investigation-of-the-contents-and-prognostic-values-of-glucose-metabolism-molecules-in-patients-with-lung-adenocarcinoma-51106 https://curecurrent.com/trials/a-study-of-alectinib-ch5424802-ro5424802-in-participants-with-anaplastic-lymphoma-kinase-alk-rearranged-non-small-cell-l-51107 https://curecurrent.com/trials/weekly-topotecan-with-docetaxel-in-recurrent-small-cell-lung-cancer-51108 https://curecurrent.com/trials/adaptive-radiotherapy-in-non-small-cell-lung-cancer-nsclc-51109 https://curecurrent.com/trials/study-of-anlotinib-plus-chemotherapy-as-the-first-line-treatment-in-patients-with-advanced-nsclc-51110 https://curecurrent.com/trials/study-for-patients-with-lung-metastatic-advanced-gastric-cancer-and-nsclc-treated-with-apatinib-51111 https://curecurrent.com/trials/perioperative-study-of-exercise-training-in-patients-with-operable-cancer-of-the-gastroesophageal-junction-51112 https://curecurrent.com/trials/phase-ii-study-of-buparlisib-docetaxel-in-advanced-or-metastatic-squamous-non-small-cell-lung-cancer-nsclc-patients-51113 https://curecurrent.com/trials/pulmonary-rehabilitation-for-uncontrolled-asthma-associated-with-elevated-bmi-51114 https://curecurrent.com/trials/neoadjuvant-compound-121564-plus-platinum-doublet-chemotherapy-in-non-small-cell-lung-cancer-51115 https://curecurrent.com/trials/first-line-combination-treatment-based-on-anlotinib-51116 https://curecurrent.com/trials/intervention-to-improve-supportive-care-for-family-caregivers-of-patients-with-lung-cancer-51117 https://curecurrent.com/trials/gemcitabine-plus-radiation-therapy-or-combination-chemotherapy-in-treating-patients-with-non-small-cell-lung-cancer-51118 https://curecurrent.com/trials/study-of-efficacy-and-safety-of-dabrafenib-and-trametinib-combination-therapy-in-japanese-patients-with-braf-v600e-stage-51119 https://curecurrent.com/trials/rovalpituzumab-tesirine-sc16ld6-5-in-recurrent-small-cell-lung-cancer-51120 https://curecurrent.com/trials/is-video-assisted-thoracoscopic-lobectomy-a-clinical-alternative-for-surgically-resectable-pathologic-n2-nsclc-patients-51121 https://curecurrent.com/trials/neoadjuvant-platinum-based-chemotherapy-for-patients-with-resectable-non-small-cell-lung-cancer-with-switch-to-chemother-51122 https://curecurrent.com/trials/a-study-evaluating-dalotuzumab-mk-0646-in-combination-with-erlotinib-for-participants-with-non-small-cell-lung-cancer-mk-51123 https://curecurrent.com/trials/atelectasis-formation-using-hfjv-during-stereotactic-solid-organ-ablations-51124 https://curecurrent.com/trials/paclitaxel-albumin-stabilized-nanoparticle-formulation-and-sunitinib-as-first-line-therapy-in-treating-patients-with-sta-51125 https://curecurrent.com/trials/the-feasibility-and-advantages-of-painless-indwelling-catheter-in-uniportal-vats-lobectomy-of-lung-cancer-51126 https://curecurrent.com/trials/recovery-and-rehabilitation-after-lung-cancer-surgery-51127 https://curecurrent.com/trials/mobile-lung-nodule-observatory-for-worldwide-evidenced-based-research-51128 https://curecurrent.com/trials/telephonic-contact-and-subsequent-physical-follow-up-treated-lung-cancer-patients-51129 https://curecurrent.com/trials/clinical-study-of-combined-radical-operation-with-postoperative-adjuvant-chemotherapy-and-prophylactic-cranial-irradiati-51130 https://curecurrent.com/trials/atezolizumab-monotherapy-and-consequent-therapy-with-atezolizumab-plus-bevacizumab-for-nsclc-51131 https://curecurrent.com/trials/ss1-dsfv-pe38-plus-pemetrexed-and-cisplatin-to-treat-malignant-pleural-mesothelioma-51132 https://curecurrent.com/trials/brown-adipose-tissue-activity-and-energy-metabolism-in-cachexia-51133 https://curecurrent.com/trials/endostar-combine-with-radiotherapy-in-brain-metastasis-of-nsclc-51134 https://curecurrent.com/trials/phase-ii-study-of-therapy-with-ps-341-in-patients-with-advanced-stage-non-small-cell-lung-cancer-51135 https://curecurrent.com/trials/enhanced-quitline-intervention-in-smoking-cessation-for-patients-with-non-metastatic-lung-cancer-51136 https://curecurrent.com/trials/cpi-613-and-docetaxel-in-treating-patients-with-stage-iiib-or-iv-non-small-cell-lung-cancer-51137 https://curecurrent.com/trials/radiation-therapy-with-combination-immunotherapy-for-relapsed-refractory-metastatic-melanoma-51138 https://curecurrent.com/trials/thermal-ablation-combined-with-external-beam-radiation-therapy-for-patients-with-inoperable-non-small-cell-lung-cancer-3-51139 https://curecurrent.com/trials/s0124-cisplatin-combined-with-irinotecan-or-etoposide-for-extensive-stage-small-cell-lung-cancer-51140 https://curecurrent.com/trials/study-to-assess-the-effect-of-azd9291-on-the-blood-levels-of-rosuvastatin-in-patients-with-egfrm-non-small-cell-lung-can-51141 https://curecurrent.com/trials/can-recurrence-of-hamartomas-be-prevented-51142 https://curecurrent.com/trials/a-study-for-tyrosine-kinase-inhibitors-discontinuation-51143 https://curecurrent.com/trials/patient-function-fitness-and-psychosocial-health-in-improving-health-related-quality-of-life-in-patients-with-stage-i-iv-51144 https://curecurrent.com/trials/azacitidine-and-entinostat-before-chemotherapy-in-treating-patients-with-advanced-non-small-cell-lung-cancer-51145 https://curecurrent.com/trials/phase-i-study-of-the-combination-of-anlotinib-with-gefitinib-51146 https://curecurrent.com/trials/intraoperative-ultrasonographic-localization-of-pulmonary-nodules-in-vats-51147 https://curecurrent.com/trials/safety-and-efficacy-clinical-study-of-sns-595-in-patients-with-advanced-small-cell-lung-cancer-51148 https://curecurrent.com/trials/sunitinib-malate-in-treating-patients-with-small-cell-lung-cancer-51149 https://curecurrent.com/trials/a-trial-of-shr-1210-in-combination-with-shr6390-in-patients-with-advanced-crc-nsclc-and-hcc-51150 https://curecurrent.com/trials/study-of-oral-cmet-inhibitor-inc280-in-chinese-patients-with-egfr-wild-type-advanced-non-small-cell-lung-cancer-nsclc-51151 https://curecurrent.com/trials/study-of-the-application-of-cpap-to-reduce-complications-and-improve-lung-cancer-ablation-radiofrequency-treatment-51152 https://curecurrent.com/trials/gemcitabine-hydrochloride-or-pemetrexed-disodium-and-carboplatin-with-or-without-celecoxib-in-treating-patients-with-adv-51153 https://curecurrent.com/trials/role-of-pet-scan-in-the-evaluation-of-early-response-to-maintenance-treatment-in-advanced-non-small-cell-lung-cancer-51154 https://curecurrent.com/trials/7-hydroxystaurosporine-and-topotecan-hydrochloride-in-treating-patients-with-relapsed-or-progressed-small-cell-lung-canc-51155 https://curecurrent.com/trials/optimizing-the-therapeutic-dose-of-apatinib-mesylate-tablets-in-patients-with-lung-cancer-by-dose-titration-a-real-world-51156 https://curecurrent.com/trials/genomic-profiling-in-previously-untreated-metastatic-non-small-cell-lung-cancer-51157 https://curecurrent.com/trials/anlotinib-plus-chemotherapy-for-patients-with-advanced-non-small-cell-lung-cancer-51158 https://curecurrent.com/trials/icotinib-as-consolidation-therapy-after-chemoradiotherapy-in-egfr-mutant-stage-iiia-iiib-non-small-cell-lung-cancer-51159 https://curecurrent.com/trials/the-effect-of-lt-to-rt-shunt-using-veno-veno-arterial-extracorporeal-membrane-oxygenation-ecmo-on-coronary-oxygenation-i-51160 https://curecurrent.com/trials/an-outcome-analysis-for-stereotactic-body-radiation-therapy-sbrt-treatment-of-non-small-lung-cancer-patients-using-4d-pe-51161 https://curecurrent.com/trials/phase-ii-study-for-previously-untreated-subjects-with-non-small-cell-lung-cancer-nsclc-or-small-cell-lung-cancer-sclc-51162 https://curecurrent.com/trials/icotinib-as-neoadjuvant-and-adjuvant-therapy-in-egfr-mutant-stage-iiib-or-oligometastasis-non-small-cell-lung-cancer-51163 https://curecurrent.com/trials/auy922-in-patient-with-stage-iv-nsclc-51164 https://curecurrent.com/trials/locally-invasive-nsclc-treated-with-neo-adjuvant-stereotactic-body-radiotherapy-and-resection-51165 https://curecurrent.com/trials/nk-cell-based-immunotherapy-as-maintenance-therapy-for-small-cell-lung-cancer-51166 https://curecurrent.com/trials/endostar-in-combination-with-chemoradiotherapy-in-patient-with-advanced-non-small-cell-lung-cancer-51167 https://curecurrent.com/trials/icotinib-versus-placebo-as-adjuvant-therapy-in-egfr-mutant-lung-adenocarcinoma-51168 https://curecurrent.com/trials/muscle-wasting-in-hemodialysis-patient-51169 https://curecurrent.com/trials/bortezomib-and-cisplatin-as-first-line-therapy-in-treating-patients-with-malignant-mesothelioma-51170 https://curecurrent.com/trials/pazopanib-hydrochloride-or-a-placebo-in-treating-patients-with-non-small-cell-lung-cancer-who-have-received-first-line-c-51171 https://curecurrent.com/trials/comparison-of-22-gauge-and-19-gauge-aspiration-needle-during-ebus-tbna-51172 https://curecurrent.com/trials/adaptive-radiotherapy-in-locally-advanced-non-small-cell-lung-cancer-lartia-trial-51173 https://curecurrent.com/trials/csmart-liquid-biopsy-and-dynamic-monitor-of-nsclc-patients-in-inner-mongolia-china-51174 https://curecurrent.com/trials/bevacizumab-and-erlotinib-in-lung-cancer-with-brain-metastases-a-phase-ii-trial-51175 https://curecurrent.com/trials/venous-thromboembolism-in-advanced-lung-cancer-51176 https://curecurrent.com/trials/study-of-nintedanib-plus-bevacizumab-in-advanced-solid-tumors-51177 https://curecurrent.com/trials/selumetinib-in-combination-with-gefitinib-in-nsclc-patients-51178 https://curecurrent.com/trials/a-study-of-ly01008-and-bevacizumab-combined-with-paclitaxel-and-carboplatin-for-treatment-of-na-ve-subjects-with-metasta-51179 https://curecurrent.com/trials/tumor-cell-vaccines-and-iscomatrix-with-chemotherapy-after-tumor-removal-51180 https://curecurrent.com/trials/photodynamic-therapy-using-porfimer-sodium-in-treating-patients-with-non-small-cell-lung-cancer-and-bronchial-disease-51181 https://curecurrent.com/trials/frailty-index-and-geriatric-assessment-in-predicting-toxicity-to-front-line-chemotherapy-in-treating-patients-with-stage-51182 https://curecurrent.com/trials/neuroprotective-effects-of-lithium-in-patients-with-small-cell-lung-cancer-undergoing-radiation-therapy-to-the-brain-51183 https://curecurrent.com/trials/bioelectrical-impedance-phase-angle-in-predicting-treatment-outcome-in-patients-with-extensive-stage-small-cell-lung-can-51184 https://curecurrent.com/trials/adjuvant-oral-decitabine-and-tetrahydrouridine-with-or-without-celecoxib-in-people-undergoing-pulmonary-metastasectomy-51185 https://curecurrent.com/trials/effect-of-talactoferrin-in-adults-with-non-small-cell-lung-cancer-51186 https://curecurrent.com/trials/evaluation-of-lucanthone-to-whole-brain-radiation-therapy-in-patients-with-brain-metastases-from-non-small-cell-lung-can-51187 https://curecurrent.com/trials/18f-flt-imaging-studies-of-treatment-response-for-lung-cancer-and-thymoma-51188 https://curecurrent.com/trials/cpi-613-in-treating-patients-with-relapsed-or-refractory-small-cell-lung-cancer-51189 https://curecurrent.com/trials/azd2014-and-weekly-paclitaxel-in-squamous-nsclc-51190 https://curecurrent.com/trials/quality-of-life-and-survivorship-care-in-patients-undergoing-hyperthermic-intraperitoneal-chemotherapy-hipec-51191 https://curecurrent.com/trials/molecular-and-diagnostic-classification-of-non-small-cell-lung-cancer-from-fine-needle-aspirates-51192 https://curecurrent.com/trials/mindful-movement-and-breathing-to-improve-outcomes-of-gynecologic-surgery-51193 https://curecurrent.com/trials/neratinib-with-and-without-temsirolimus-for-patients-with-her2-activating-mutations-in-non-small-cell-lung-cancer-51194 https://curecurrent.com/trials/cryotherapy-in-treating-patients-with-lung-cancer-that-has-spread-to-the-other-lung-or-parts-of-the-body-51195 https://curecurrent.com/trials/study-of-nivolumab-plus-chemotherapy-in-patients-with-advanced-cancer-nivoplus-51196 https://curecurrent.com/trials/genomic-sequencing-in-determining-treatment-in-patients-with-metastatic-cancer-or-cancer-that-cannot-be-removed-by-surge-51197 https://curecurrent.com/trials/carboplatin-plus-etoposide-with-or-without-mpdl3280a-in-untreated-extensive-stage-small-cell-lung-cancer-51198 https://curecurrent.com/trials/healthy-directions-after-lung-surgery-pilot-51199 https://curecurrent.com/trials/docetaxel-cisplatin-pegfilgrastim-and-erlotinib-hydrochloride-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-51200 https://curecurrent.com/trials/methylprednisolone-before-fludeoxyglucose-labeled-positron-emission-tomography-in-patients-with-lung-cancer-51201 https://curecurrent.com/trials/effect-of-qigong-on-the-symptom-clusters-of-dyspnea-fatigue-and-anxiety-51202 https://curecurrent.com/trials/safety-and-tolerability-study-of-isis-eif4e-rx-in-combination-with-carboplatin-and-paclitaxel-51203 https://curecurrent.com/trials/ambulatory-oxygen-in-fibrotic-lung-disease-fld-ambox-51204 https://curecurrent.com/trials/the-pittsburgh-vitamin-d-study-vitamin-d-supplementation-in-vitamin-d-deficient-subjects-at-risk-of-lung-cancer-51205 https://curecurrent.com/trials/audio-technology-to-detect-lung-cancer-earlier-51206 https://curecurrent.com/trials/phase-i-study-of-the-combination-of-anlotinib-with-pemetrexed-or-docetaxel-51207 https://curecurrent.com/trials/roniciclib-placebo-in-combination-with-chemotherapy-in-small-cell-lung-cancer-51208 https://curecurrent.com/trials/pet-dect-for-staging-and-imaged-based-radiotherapy-planning-in-lung-cancer-51209 https://curecurrent.com/trials/effect-of-iloprost-on-pulmonary-oxygenation-in-patients-with-low-diffusing-capacity-during-one-lung-ventilation-51210 https://curecurrent.com/trials/azd6244-in-combination-with-docetaxel-versus-docetaxel-alone-in-kras-mutation-positive-nsclc-patients-51211 https://curecurrent.com/trials/postoperative-pain-control-with-lipossomic-extended-release-bupivacaine-51212 https://curecurrent.com/trials/combination-of-metformin-with-gefitinib-to-treat-nsclc-51213 https://curecurrent.com/trials/evaluation-of-a-new-anti-cancer-vaccine-for-patients-with-non-small-cell-lung-cancer-after-tumor-removal-by-surgery-51214 https://curecurrent.com/trials/ip3r-modulation-by-cancer-genes-in-mesothelioma-51215 https://curecurrent.com/trials/impact-of-aferbio-on-quality-of-life-and-chemotherapy-toxicity-in-lung-cancer-patients-51216 https://curecurrent.com/trials/phase-ii-trial-of-carboplatin-and-pemetrexed-ogx-427-in-untreated-stage-iv-non-squamous-non-small-cell-lung-cancer-51217 https://curecurrent.com/trials/radiation-therapy-in-preventing-central-nervous-system-cns-metastases-in-patients-with-non-small-cell-lung-cancer-51218 https://curecurrent.com/trials/nir-fluorescence-imaging-technique-in-thoracic-surgery-with-icg-51219 https://curecurrent.com/trials/pxd101-as-second-line-therapy-in-treating-patients-with-malignant-mesothelioma-of-the-chest-that-cannot-be-removed-by-su-51220 https://curecurrent.com/trials/intermittent-and-maintenance-of-icotinib-in-combination-with-pemetrexed-carboplatin-compared-with-icotinib-single-drug-i-51221 https://curecurrent.com/trials/paclitaxel-carboplatin-and-bevacizumab-with-or-without-cixutumumab-in-treating-patients-with-stage-iv-or-recurrent-non-s-51222 https://curecurrent.com/trials/varenicline-or-nicotine-patch-and-nicotine-gum-in-helping-smokers-in-a-methadone-treatment-program-stop-smoking-51223 https://curecurrent.com/trials/a-phase-1-2a-study-of-abt-263-in-subjects-with-small-cell-lung-cancer-sclc-or-other-non-hematological-malignancies-51224 https://curecurrent.com/trials/comparison-of-veliparib-and-whole-brain-radiation-therapy-wbrt-versus-placebo-and-wbrt-in-adults-with-brain-metastases-f-51225 https://curecurrent.com/trials/calcitriol-in-preventing-lung-cancer-in-smokers-and-former-smokers-at-high-risk-of-lung-cancer-51226 https://curecurrent.com/trials/predicting-tolerance-to-radiation-therapy-in-older-adults-with-cancer-51227 https://curecurrent.com/trials/a-study-of-imc-a12-cixutumumab-with-and-without-other-standard-chemotherapies-in-participants-with-lung-cancer-who-have-51228 https://curecurrent.com/trials/dabrafenib-and-trametinib-in-patients-with-non-small-cell-lung-cancer-harboring-v600e-braf-mutation-51229 https://curecurrent.com/trials/combined-diagnosis-of-ct-and-exosome-in-early-lung-cancer-51230 https://curecurrent.com/trials/personalized-dc-vaccine-for-lung-cancer-51231 https://curecurrent.com/trials/study-of-vandetanib-combined-with-chemotherapy-to-treat-advanced-non-small-cell-lung-cancer-51232 https://curecurrent.com/trials/phase-i-hypofractionated-stereotactic-boost-radiotherapy-for-non-small-cell-lung-cancer-51233 https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-inhaled-laninamivir-octanoate-twincaps-dpi-in-adults-with-chronic-asthma-51234 https://curecurrent.com/trials/anti-ctla-4-antibody-followed-by-anti-pd-1-antibody-in-recurrent-or-metastatic-nsclc-51235 https://curecurrent.com/trials/right-ventricular-inflammation-after-lung-resection-51236 https://curecurrent.com/trials/feasibility-study-of-tumor-blood-flow-measurement-by-detection-of-positron-activation-post-proton-therapy-ds01-51237 https://curecurrent.com/trials/molecular-signatures-of-relapse-in-tissue-samples-from-patients-with-small-cell-lung-cancer-who-are-receiving-cisplatin-51238 https://curecurrent.com/trials/poziotinib-in-stage-iv-lung-adenocarcinoma-with-her2-mutation-kastt001-51239 https://curecurrent.com/trials/feasibility-study-of-navigated-endoscopy-for-the-placement-of-high-dose-rate-brachytherapy-applicators-in-the-esophagus-51240 https://curecurrent.com/trials/the-jules-bordet-institute-molecular-profiling-program-feasibility-trial-51241 https://curecurrent.com/trials/irinotecan-for-previously-treated-advanced-non-small-cell-lung-cancer-51242 https://curecurrent.com/trials/local-therapies-for-oligometastatic-non-small-cell-lung-cancer-harboring-sensitizing-egfr-mutations-51243 https://curecurrent.com/trials/a-study-to-explore-clinical-characteristics-and-prognoses-of-n2-patients-with-non-small-cell-lung-cancer-51244 https://curecurrent.com/trials/a-study-to-evaluate-effectiveness-and-safety-of-surgeries-in-elderly-nsclc-patients-51245 https://curecurrent.com/trials/circulating-tumor-dna-detection-in-surveillance-of-surgical-lung-cancer-patients-51246 https://curecurrent.com/trials/a-study-to-evaluate-clinical-characteristics-of-lung-cancer-in-patients-with-surgeries-and-adjuvant-therapies-51247 https://curecurrent.com/trials/a-study-to-evaluate-effectiveness-of-sublobar-dissection-in-patients-with-non-small-cell-lung-cancer-51248 https://curecurrent.com/trials/an-observational-study-to-explore-clinical-characteristics-of-the-patients-with-t1-non-small-cell-lung-cancer-51249 https://curecurrent.com/trials/a-study-to-explore-prognoses-of-the-patients-with-n2-non-small-cell-lung-cancer-51250 https://curecurrent.com/trials/meditation-based-breathing-training-in-improving-target-motion-management-and-reducing-distress-in-patients-with-abdomin-51251 https://curecurrent.com/trials/a-study-in-non-small-cell-lung-cancer-51252 https://curecurrent.com/trials/topotecan-and-vinorelbine-in-treating-patients-with-recurrent-lung-cancer-51253 https://curecurrent.com/trials/study-to-assess-safety-and-tolerability-of-mln8237-in-combination-with-erlotinib-to-treat-non-small-cell-lung-cancer-51254 https://curecurrent.com/trials/anti-muc1-car-t-cells-and-pd-1-knockout-engineered-t-cells-for-nsclc-51255 https://curecurrent.com/trials/surgical-versus-non-surgical-staging-of-lung-cancer-51256 https://curecurrent.com/trials/study-of-px-866-and-docetaxel-in-solid-tumors-51257 https://curecurrent.com/trials/pilot-study-of-novel-fluorescence-endoscopic-device-for-sentinel-lymph-node-mapping-in-lung-cancer-51258 https://curecurrent.com/trials/home-respiratory-rehabilitation-in-advanced-lung-cancer-chemotherapy-per-os-51259 https://curecurrent.com/trials/a-phase-ib-trial-of-a-maintenance-multipeptide-vaccine-s-588210-in-patients-with-unresectable-malignant-pleural-mesothel-51260 https://curecurrent.com/trials/thin-ebus-in-ex-vivo-human-lungs-51261 https://curecurrent.com/trials/an-observational-study-of-avastin-bevacizumab-in-elderly-patients-with-non-squamous-non-small-cell-lung-cancer-in-clinic-51262 https://curecurrent.com/trials/ebus-tbna-vs-flex-19g-ebus-tbna-51263 https://curecurrent.com/trials/stereotactic-radiosurgery-in-treating-patients-with-stage-i-or-stage-ii-non-small-cell-lung-cancer-51264 https://curecurrent.com/trials/retrospective-comparative-study-of-routine-lower-neck-ct-in-the-staging-and-diagnosis-of-lung-cancer-across-two-cohorts-51265 https://curecurrent.com/trials/nk-cell-activity-in-smokers-screened-for-lung-cancer-51266 https://curecurrent.com/trials/study-of-autologous-immune-killer-cells-in-patients-with-late-stage-hepatocellular-carcinoma-or-lung-cancer-51267 https://curecurrent.com/trials/lung-stereotactic-body-radiotherapy-sbrt-delivered-over-4-days-versus-11-days-51268 https://curecurrent.com/trials/mechanisms-of-immunosurveillance-for-lung-cancer-51269 https://curecurrent.com/trials/the-emprint-ablate-and-resect-study-in-patients-with-metastatic-lung-tumors-empress-51270 https://curecurrent.com/trials/spectrum-analysis-in-ex-vivo-human-lungs-51271